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Abstract
A major intracellular calcium (Ca2+) uptake pathway in excitable and non-excitable
eukaryotic cells is store-operated Ca2+ entry (SOCE). Stromal interaction molecule-1
(STIM1) is the key regulator of SOCE and responds to changes in endoplasmic reticulum
(ER)-stored Ca2+ through luminal sensing machinery composed of EF-hand and SAM
domains (EFSAM). EFSAM can undergo N-glycosylation at Asn131 and Asn171 sites;
however, the exact molecular and functional effects of N-glycosylation are unclear. By
establishing a site-specific chemical approach to covalently linking glucose to EFSAM and
subsequently examining EFSAM biophysical properties, I found that this modification
enhances STIM1 activation through localized structural perturbations, decreased Ca2+
binding affinity, reduced stability and enhanced oligomerization. Further, Ca2+ influx via
SOCE in HEK293 cells co-expressing Orai1 and STIM1 was diminished when Nglycosylation was blocked. Collectively, my data suggests that N-glycosylation enhances
EFSAM response to ER Ca2+ depletion thereby augmenting the role of STIM1 as the
ON/OFF regulator of SOCE.
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Chapter 1
Introduction
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1.1 Calcium
Calcium ions (Ca2+) are essential for numerous intracellular signals that regulate a
plethora of cellular processes and are necessary to maintain cellular homeostasis. For
example, at the synaptic junction, Ca2+ triggers exocytosis within microseconds, whereas
Ca2+ has to signal over minutes to hours to drive events such as transcription and cell
proliferation (Berridge et al., 2003). Therefore, precise control of Ca2+ levels in the
cytoplasm is crucial for mediating these important processes. Furthermore, recognizing how
these different Ca2+ signaling systems work and studying the delicate balance between the
production and removal of Ca2+ signals in the cytoplasm is important for understanding the
basis for myriad processes in both health and disease (Berridge et al., 2003).
While each cell type possesses unique Ca2+ signaling properties, most systems
function by transient Ca2+ pulses generated from a combination of addition and removal of
cytosolic Ca2+ (Figure 1.1). The release of Ca2+ into the cytoplasm can be derived either from
internal cellular stores or the external medium. The endoplasmic reticulum (ER) is
considered to be a major internal Ca2+ store (Berridge, 1993; Clapham, 1995) with Ca2+
levels maintained in the ~100-800 µM range. Release of Ca2+ from the ER lumen is mediated
by Ca2+ itself or by other messengers, such as inositol 1,4,5-trisphosphate (IP3). For example,
the activation of G-protein coupled receptors (GPCR) on the plasma membrane (PM) leads to
the activation of phospholipases, in turn resulting in the metabolism of phosphatidylinositol
4,5-biphosphate generating diacylglycerol and IP3. IP3 is a small diffusible molecule that
binds to the IP3 receptor on the cytosolic side of ER membrane. IP3 receptor which is also a
channel, opens upon stimulation causing the release of Ca2+ from the lumen and into the
cytoplasm (i.e., ~0.1-1 µM) (Bootman et al., 2001; Berridge et al., 2003).

3
Ca2+

Extracellular Space
[Ca2+] = ~1000 µM

Stimulus

SOCE
Pathway

Cytoplasm
[Ca2+] = 0.1-1 µM

R

IP3
Uniporter
Ca2+

Mitochondria
[Ca2+] = 0.1-1 µM
SERCA
Na+

Na+
NCX
NCX

Ca2+
Ca2+

Ca2+
PMCA

ER/SR
[Ca2+] = 100-800 µM

Buffers
EFFECTORS
Proliferation, Transcription, Metabolism, Contraction, Exocytosis

Figure 1.1. Schematic diagram of the Ca2+ signaling pathway and homeostasis.
This diagram was modified from Berridge et al., 2003. Plasma membrane GPCRs,
TCRs and RTKs are shown in green, labeled as R. Downstream of PM receptor
activation, the second messenger IP3 binds to its receptor on the S/ER membrane
depicted in blue. Binding of IP3 to the IP3 receptor causes efflux of Ca2+ from the S/ER
lumen and depletion of this major intracellular Ca2+ store. The S/ER Ca2+ depletion
activates PM Ca2+ channels (grey square) and Ca2+ influx from the extracellular space
ensues in the process of SOCE. The process is fully reversible once the Ca2+ store in S/
ER lumen is replenished by the SERCA pump. Mitochondria also sequesters cytosolic
Ca2+ quickly through a uniporter, and then released slowly for SERCA and Ca2+ATPase (PMCA) uptake. Most cytosolic Ca2+ are bound to buffers, whereas a small
proportion binds to the effectors to mediate various cellular processes. When these
signals are no longer needed nor present, Ca2+ is removed from the cells by various
exchangers and pumps such as Na+/Ca2+ exchanger (NCX), PMCA, SERCA.
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Although the ER lumen is a major intracellular Ca2+ store, it is only a limited and
exhaustible source of Ca2+. Whereas local and acute increases in cytosolic Ca2+ may trigger
many processes, many of them rely on prolonged cytosolic Ca2+ signals to elicit responses
such as gene transcription and cell proliferation (Hogan et al., 2003). Therefore, for
maintained increases in cytosolic Ca2+ levels, an influx of Ca2+ is required beyond what is
capable of being sourced from the ER. The extracellular space represents an essentially
inexhaustible source of Ca2+ (i.e., >1000 µM), which can facilitate maintained increases in
cytosolic Ca2+. Thus, opening of Ca2+ channels on the plasma membrane can result in an
influx of Ca2+ down a steep concentration gradient (Feske, 2007). Importantly, the uptake of
Ca2+ from the extracellular space is needed not only to sustain elevated cytosolic Ca2+ levels,
but also to prevent depletion of ER Ca2+ levels and to replenish the ER Ca2+ stores. One of
the major pathways that regulates ER Ca2+ levels and facilitates extracellular space Ca2+
influx is the store operated Ca2+ entry (SOCE) pathway (Putney, 1986).

1.2 Store operated Ca2+ entry (SOCE)
1.2.1 Discovery of the SOCE pathway
SOCE is a major Ca2+ entry pathway in excitable and non-excitable cells (VargaSzabo et al., 2011; Shaw & Feske, 2013). Starting from the discovery and appreciation for
the role of Ca2+ as an intracellular signal over a century ago (Ringer, 1883), there was
considerable interest on the sources of such cellular Ca2+ (Rasmussen, 1970; Janis & Triggle,
1983), eventually leading to the conception of the SOCE model (Putney, 1986). The origin of
the SOCE theory is associated with an investigation of the kinetics of the potassium (K+)
permeability response in the parotid gland using a unidirectional isotope flux technique
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(Putney, 1976). This experiment revealed increased K+ permeability in two phases: a
transient phase followed by a sustained phase. Interestingly, Putney and his colleagues also
found that in the absence of extracellular Ca2+, only the sustained phase was no longer
present (Putney, 1976). Moreover, it was demonstrated that the initial transient response was
dependent on Ca2+ from inside the cell, and it could only be restored by external Ca2+ via
plasma membrane Ca2+ channels, and upon depletion of the internal Ca2+ store (Parod &
Putney, 1978). It was only realized 8 years later that the influx of Ca2+ to restore the internal
Ca2+ levels was not a direct consequence of the activation of the plasma membrane GPCRs,
but rather it was a result of the depletion of the Ca2+ levels in the intracellular stores (Putney,
1986).

1.2.2 Molecular players mediating SOCE
SOCE, also known as capacitative Ca2+ entry, occurs subsequently to the release of
intracellular Ca2+ stores, thereby causing an influx of Ca2+ from the extracellular space into
the cytoplasm. Specifically, decreases in ER luminal Ca2+ levels result in the interaction
between ER- and PM-resident proteins, which open PM Ca2+ channels that facilitate influx of
Ca2+

from

the

extracellular

space,

thus

elevating

cytosolic

Ca2+

levels

and

replenishing/maintaining high levels of Ca2+ in the ER lumen (Putney, 1986). In addition to
the previously mentioned GPCRs in section 1.1, there is large range of other PM receptors
that lead to IP3 production and subsequently to the depletion of ER Ca2+ stores, such as T-cell
receptors (TCR) (van Leeuwen & Samelson, 1999; Lucas et al., 2003) and receptor tyrosine
kinases (RTK) (Clapham, 1995; Schlessinger, 2000) (Figure 1.1). Following the efflux, the
decrease in Ca2+ levels within ER lumen is detected and signals are sent to the PM of the cell
to open Ca2+ channels and allow external Ca2+ to move down the concentration gradient into
the cytosol.
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These Ca2+ ions not only elevate the cytosolic levels of Ca2+ but are also an important source
for sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) pumps located on ER membrane to
recycle Ca2+ back into the ER lumen. It is important to note that the ER is not only a source
of Ca2+, but this organelle also carries out critical processes that are Ca2+ dependent such as
protein folding, vesicle trafficking, initiation of apoptosis, and many others (Berridge, 2002).
Although the concept of SOCE was first proposed in 1986, it was not until two
decades later that the principal molecular players in this process were identified. Liou and
colleagues generated small interfering RNAs (siRNAs) against 2,304 proteins with known
human signaling domains identified in the National Center for Biotechnology Information
database and used them to test their role in receptor triggered Ca2+ signals in HeLa cells
(Liou et al., 2005). HeLa cells were stimulated with histamine, a GPCR ligand (Hill, 1990;
Leurs et al., 1995), and thapsigargin (TG), a non-competitive SERCA pump inhibitor
(Jackson et al., 1988; Lytton et al., 1991; Treiman et al., 1998), fura2., a small molecule
fluorescent cytosolic Ca2+ indicator, was used to assess the peak of the cytosolic Ca2+
increase followed by the plateau (Liou et al., 2005). The observed plateau phase was due to
maintenance of high cytosolic Ca2+ levels from the activated SOCE pathway. Knockdown of
stromal interaction molecule (STIM) proteins that are involved in the SOCE pathway
resulted in a near complete loss of the cytosolic Ca2+ plateau due to downregulation of the a
vital molecular component of the SOCE pathway (Liou et al., 2005). STIM1 and STIM2
siRNA transfected cells showed a significantly reduced plateau of cytosolic Ca2+ levels and
the reduction of this level was detected following the same magnitude of initial Ca2+ peak
(i.e., same level of transient Ca2+ release from the ER store). Interestingly, these two proteins
had already been biochemically characterized to some extent even prior to the discovery of
their link to SOCE. Specifically, STIM1 and STIM2 were known to contain a transmembrane
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(TM) domain, an EF-hand Ca2+ binding domain, and were found to form homo- and heterooligomers (Williams et al., 2001, 2002). Consequently, Liou et al. (2005) concluded that the
two homologues, STIM1 and STIM2, must be the critical players of SOCE.
An independent study by Roos and colleagues (Roos et al., 2005) investigated the
essential players of the SOCE pathway in Drosophila S2 cells. They suppressed several
targeted genes using RNA interference (RNAi), and by using TG and fura2, they discovered
the Drosophila STIM orthologue protein was vital for mediating SOCE in this cell type.
Furthermore, to distinguish which of the two mammalian homologues, STIM1 or STIM2, is
responsible for SOCE, Roos and colleagues performed RNAi-mediated knockdown of
human STIM1 in HEK293 and SH-SY5Y neuroblastoma cells over expressing STIM1 (Roos
et al., 2005). In both cases, cells displayed reduced Ca2+ influx upon TG treatment. However,
knockdown of STIM2 in these cells showed unaltered levels of Ca2+ influx. Therefore, Roos
et al. (2005) concluded STIM1, a protein that is ubiquitously expressed and conserved from
Drosophila to mammalian cells, is an essential molecular player in SOCE.
In 2006, Prakriya and colleagues identified a protein called Orai1, a previously
uncharacterized protein with four putative TM segments, to be involved in the SOCE
pathway (Prakriya et al., 2006). They performed a pedigree analysis to identify the missense
mutation in Orai1 leading to defective Ca2+ entry via SOCE associated with severe combined
immunodeficiency disease (SCID) (Feske et al., 2006; Prakriya et al., 2006). Furthermore,
other groups that conducted a genome-wide RNAi screen in Drosophila cells to identify the
gene responsible for SOCE Ca2+ influx similarly identified the orthologue of human Orai1
(Yeromin et al., 2006; Zhang et al., 2006a). Based on these early studies we now know that
the identities of the molecules that mediate SOCE include the ER-inserted STIM proteins and
the PM-resident Orai proteins. Importantly, it was found that co-overexpression of STIM1
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and Orai1 results in very large increases (5-10-fold) in sustained cytosolic Ca2+ levels after
ER lumen Ca2+ store depletion using TG, further reinforcing the role of STIM1 and Orai1 in
the SOCE pathway (Mercer et al., 2006). Additionally, when STIM1 interacted with Orai1
reconstituted in liposomes, a SOCE-like phenomenon was observed indicating that these
proteins are the minimal requirements for SOCE (Gudlur et al., 2014).

1.3 Stromal interaction molecule (STIM) and Orai
1.3.1 STIM and Orai domain architectures
After the discovery of STIM and Orai proteins as the principal molecular players of
SOCE, determining the three-dimensional (3D) atomic resolution structure of these proteins
was vital to understanding the precise mechanisms activating the SOCE pathway.

1.3.1.1

STIM domain architectures

STIM proteins are single-pass type I TM proteins and, in vertebrates, there are two
homologues, STIM1 and STIM2. Although it was discovered that a small fraction of STIM1
is located on the PM, STIM proteins are mainly localized to the ER membrane (Manji et al.,
2000; Williams et al., 2001; Zhang et al., 2005; Cai, 2007a). The ER lumen-oriented region
of STIM is composed of EF-hand and sterile α-motif (SAM) domains, and immediately
following the TM domain there are three coiled-coil (CC) domains located on the cytosolic
side of the protein (Figure 1.2). A long CC1 is located closest to the TM domain followed
immediately by two shorter CC domains (i.e., CC2 and CC3); further, proximal to the CC
region are proline- and serine-rich regions and lysine-rich region near the C-terminus (Figure
1.2) (Stathopulos & Ikura, 2013a). The sequence comparison of the two human STIM
homologues as well as STIMs from lower to higher eukaryotes (Stathopulos & Ikura, 2013a),
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reveals that the above mentioned domains are conserved, suggesting that they are vital to the
function of STIM proteins across species.
There are two human STIM homologues, STIM1 and STIM2 with 76% sequence
identity (Stathopulos & Ikura, 2013a). Previously, more focus has been on studying STIM1
as the regulator of SOCE pathway activation but both homologues play a major role in
regulating Ca2+ homeostasis in the cell. STIM1 and STIM2 differ in of the manner in which
they maintain optimal Ca2+ levels in the cell with STIM1 being the ON/OFF switch of SOCE
and STIM2 directly involved in sustaining basal Ca2+ levels (Stathopulos & Ikura, 2013a).
Both STIM1 and STIM2 proteins contain an ER localization sequence near the N-terminus.
Whereas STIM1 contains a 22-residue ER signal peptide, STIM2 has an 87-residue insertion
into this N-terminal region, resulting in a much longer ER signal peptide (Stathopulos &
Ikura, 2013a). Interestingly, the longer signal peptide of STIM2 is believed to decrease its
ER localization efficiency, resulting in a small fraction of the pre-protein found in the
cytoplasm instead of inserted in the membrane. Furthermore, such cytosolic STIM2 preprotein is believed to regulate Orai1 in a Ca2+ store-independent manner, where it maintains
basal Ca2+ levels and Ca2+-dependent transcription (Graham et al., 2011). STIM1 is
expressed in most human tissues (Darbellay et al., 2011; Horinouchi et al., 2012).

(A)
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VPRHLRGRRA-TGSA-ATAASSPAAAAGDSPALMTDPCMSLSPPCFT--EEDRFSLEALQTIHKQMDDDKDGGIEVEESDEFIREDMKYK 103!
---MGRVSWII-ALYLTINV--VIVV------NGDRVTRNVEVTAEEEKIRDKLGYEAIRDIHRDMDDDHSGSIDRNESTGFMKEDMQMR 78!
AQNLHRSSYNLLSEAMSQAVSNEFSS--MGSGSADGACAADDFDCYSGSVQDRFGMEAIASLHRQLDDDDNGNIDLSESDDFLREELKYD 178!
:
.
. .
:::. **: :*: :*** .* :: .** *::*:::
!
! Noncanonical EF-hand
SAM
DPTVKHS--TFHGEDKLISVEDLWKAWKSSEVYNWTVDEVVQWLITYVELPQYEETFRKLQLSGHAMPRLAVTNTTMTGTVLKMTDRSHR 187!
DATNKHS--HLHREDKHITIEDLWKRWKTSEVHNWTLEDTLQWLIEFVELPQYEKNFRDNNVKGTTLPRIAVHEPSFMISQLKISDRSHR 191!
GSERTRRENKFHGDDDAITVDDLWEAWFESIERTWTNERLVEWLINDVNLPSIVEAVKAKKIDGKILPRFASPNSDFLNKELGIKSSVYR 168 !
SGYEKRQKAFHFNDDMHISVKELWEAWLRSEVHNWTIEQTTDWLAQSVQLPQYVDLFKLHKVTGAALPRLAVNNLQYVGNVLGIKDPIHK 270!
.:
. :* *::.:**: * *
.** :
:**
*:**. . .: :: * :**:* :
. * :.. ::!
TM
Putative coiled-coil 1
QKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCWFAYIQNR-YSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVE 276!
QKLQLKALDVVLFGPLTRPPHNWMKDFILTVSIVIGVGGCWFAYTQNK-TSKEHVAKMMKDLESLQTAEQSLMDLQERLEKAQEENRNVA 280!
QKLRLNSLDVVLFGYKDNN--NRTKDILLAFLAL-LLTSLIFLYVRQKQKAQQKVNELSNKLTELKCMETEFEDVQKMLNDERSK----- 250!
QKISLKAMDVVLFGPPRETGTRW-KDYILVTLLLSAIIGCWYAYQQNK-NAKRHLRRMAQDMEGLQRAEQSLQEMQKELERARMEQENVA 356!
**: *:::*.****
. ** :*.
: : . : * ::: ::.:: .: :.: *: * .: ::*: *. : :
!
!
!
! Putative coiled-coil 1
Coiled-coil 2!
VEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHS-SWYAPEALQKWLQLTHEVEVQYYNIK 365!
VEKQNLERKMMDEINYAKEEACRLRELREGAECELSRRQYAEQELEQVRMALKKAEKEFELRS-SWSVPDALQKWLQLTHEVEVQYYNIK 369!
------------------------RSI--------SDGVVNHTEMENLRVQLEEAERRLEANSNGSQAPLALQPLLRRTCENEMAFLEKQ 308!
TEKLDLERRLKEAPTLSSSNSD-------------LEVQQLKKEIEMLRNELSRAEFEL-VDN-CWSPPPQLQSWLQYTYELESKNHQKK 431!
. *:* :* * .** .:
.
* ** *: * * *
: :!
!
Coiled-coil 2
Coiled-coil 3!
KQNAEKQLLVAKEGAEKIKKKRNTLFGTFHVAHS--SSLDDVDHKILTAKQALSEVTAALRERLHRWQQIEILCGFQIVNNPGIHSLVAA 453!
RQNAEMQLAIAKDEAEKIKKKRSTVFGTLHVAHS--SSLDEVDHKILEAKKALSELTTCLRERLFRWQQIEKICGFQIAHNSGLPSLTSS 457!
RQDCFKEMKEAIEMVDRLQKKQGSVLSSLKLATGAASTSDQVDSKIFALKSRMEKIHTLTRETQERWLQIESLCGFPLLYLNETEHINRS 398!
RTSAEKQLQSAREACEKLRKKRSSLVGAFVSTHG--KSIDDVDRSIVEARNALGDVTNELQERLHRWKQIETCLGLNIVNNNGLPYLENV 519!
: .. :: * : ::::**: ::..:: : . .: *:** .*. :. : .:
:*
** ***
*: :
:
!

!
H.sapiens1
H.sapiens2
C.elegans
D.melanogaster

LNIDPSW----MGSTRPNPAHFIMTDDVDDMDEEIVS-PLSMQSPSLQSSVRQRLTEPQHGLGSQRDLTHSDSESSLHMSDRQRVAPKPP
LYSDHSW----VVMPRVSIPPYPIAGGVDDLDEDTPP-IVS-QFP-------GTMAKPPGSLARSSSLCR----------SRRSIVPSSP
IASSHFYNKSHEGSSSSGS----ISNAH------SNPNAVNSNFV------------------------------------KKVSPPIPP
LYGRNGGLQSSMGMSSTKGSRARITNSTEDLDDESIQGKLNFENFSLLATE--------------------------------------:
::
:. :
!

538!
524!
442!
570!

!
H.sapiens1 QMSRAADEALNAMTSNGSHRLIEGVHPGSLVEKLP------DSPALAKKA------LL----------------ALNHGLDKAH----S- 595!
H.sapiens2 QPQRAQLAPHAPHPSHPRHPHHPQHTPHSLPSPDPDILSVSSCPALYRNEEEEEAIYFSAEKQWEVPDTASECDSLNSSIGRKQSPPLSL 614!
C.elegans SQQTANL---RFVPTEQSDSIHSEDT-------SPIVEDVAISRSLTQDLAEAD-------MQ-----------SIVSGS---------- 494!
!
!
H.sapiens1 --LMELSPSAPPGGS-PHLDSSRSHSPSSPDPDT--PSPVGD------------------------------------------------ 632!
H.sapiens2 EIYQTLSPRKISRDEVSLEDSSRGDSPVTVDVSWGSPDCVGLTETKSMIFSPASKVYNGILEKSCSMNQLSSGIPVPKPRHTSCSSAGND 704!
C.elegans ---------TNGSGSVAALKKRKGIFPKLFRRNTSKSSSLGGTSN--------------------------------------------- 530!
!
!
!
!
!
!
!
Poly-K
H.sapiens1 SRALQ----ASRNTRIPHLAGKKAVAEEDNGSIGEETDSSPGRKKFPLKIFKKPLKK 685!
H.sapiens2 SKPVQEAPSVARISSIPHDLC----------HNGEKS-KKPSKI---KSLFKKKSK- 746!

Figure 1.2. STIM1 domain architecture and sequence alignment. (A) STIM1 domain
architecture. S indicates signaling peptide, cEF is the canonical EF-hand, nEF is the noncanonical
EF-hand, SAM is the sterile alpha motif domain, and TM represents transmembrane domain. The
relative positions of the Asn131 and Asn171 sites are shown as blue triangles above the domain
positions. After the TM are three coiled coil domain (i.e., CC1-3), a proline and serine rich region
(P/S) and a lysine rich region (poly-K) near the C-terminal domain. (B) Multiple sequence
alignment of human and lower order STIM proteins. H. sapiens STIM1 (NCBI, NP_003147.2), H.
sapiens STIM2 (NCBI, NP_065911.3), Caenorhabditis elegans STIM (NCBI, CCD73857.1), and
Drosophila melanogaster STIM (NCBI, NP_523357.2) sequences were aligned using Clustal
Omega (Sievers et al., 2011) with the default settings. The (*) indicates fully conserved residue, (:)
strongly similar residues, and (.) weakly similar residue. Conserved residue regions are shaded to
correspond with the domain color scheme in A; glycosylation sites are highlighted in cyan.
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1.3.1.2

Orai domain architectures

Orai proteins are PM-localized and are predicted to contain four TM domains;
further, there are three human homologues, Orai1, Orai2, and Orai3 (Cai, 2007b). The three
types of human Orai homologues share conserved primary sequence including specific
residues responsible for dictating the channel characteristics, such as ion permeability, ion
selectivity, and formation of a hydrophobic gate (Stathopulos & Ikura, 2013a). Moreover,
both N- and C-termini face the cytoplasm and are believed to play a role in the interaction
with STIM1 that mediates channel assembly and gating (Stathopulos & Ikura, 2013a). TM
segment 1 (TM1) was identified to line the Ca2+ permeation pore within the Ca2+ channel,
and Glu106 of TM1 and Glu190 of TM3 were found to form the Ca2+ binding site and
provide Ca2+ selectivity, respectively (Prakriya et al., 2006; Yeromin et al., 2006). Similar to
STIM proteins, different Orai proteins of lower order eukaryotes contain highly conserved
TM regions and loop regions located between TMs. All Orai human homologues, when
exogenously expressed have successfully formed functional Ca2+ released activated Ca2+
(CRAC) channels (Dehaven et al., 2007; Gwack et al., 2007; Lis et al., 2007; Frischauf et al.,
2009; Bogeski et al., 2010). However, the three homologues differ in sensitivity to Ca2+dependent inactivation (Lis et al., 2007) and even though Orai1, Orai2, and Orai3 are all
widely expressed across human tissues (Gwack et al., 2007; Schindl et al., 2009),
endogenous CRAC channels are only formed by the homomeric assembly of Orai1 proteins
(Mignen et al., 2008; Hou et al., 2012; Thompson & Shuttleworth, 2013). It is still unclear
how many Orai1 subunits are required to make a CRAC channel, and the two leading
possibilities for the functional stoichiometry are hexamer or tetramer (Mignen et al., 2008;
Hou et al., 2012; Thompson & Shuttleworth, 2013).
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1.3.2 STIM1 and Orai1 in the activation of SOCE
The activation of SOCE involving STIM1 and Orai1 proteins is a multistep process
(Figure 1.3). The pathway is initiated by the response of STIM1 to ER Ca2+ levels. As
mentioned above, STIM1 acts as the ER luminal Ca2+ sensor, and the luminal domain
contains a canonical Ca2+ binding EF-hand motif (Roos et al., 2005; Liou et al., 2005;
Stathopulos et al., 2006). When the Ca2+ levels in the ER are at rest (i.e., ~400-800 µM), Ca2+
ions are normally bound to the canonical EF-hand motif of STIM1. However, upon decreases
in ER luminal Ca2+ levels (i.e., ~100-400 µM) and a loss in the EF-hand Ca2+ binding, a
structural change occurs in the STIM1 luminal domain that initiates oligomerization of the
protein. The oligomerization of the STIM1 luminal domain induces structural changes in the
cytosolic region of STIM1 that enhances the oligomerization of the molecule. The
oligomerized STIM1 subsequently translocates to ER-PM junctions, forming puncta. At ERPM junctions, oligomerized STIM1 recruits Orai proteins to the same punctate aggregates
(Liou et al., 2005, 2007; Zhang et al., 2005). Puncta formation was shown using total internal
reflective fluorescence (TIRF) microscopy in HeLa and HL1 cardiomyocyte cells coexpressing monomeric cherry tagged (mCh)-STIM1 and enhanced green fluorescence protein
(eGFP)-Orai1 (Stathopulos et al., 2013). At resting ER Ca2+ levels, mCh and eGFP
fluorescence is pervasive along the ER membrane and PM, respectively. However, when TG
passively depletes the ER Ca2+ store, there is an accumulation of the fluorescence signal at
ER-PM junctions, indicating puncta formation and the co-localization of STIM1 and Orai1
proteins within ~100 nm of the surface of the cell (Stathopulos et al., 2013). STIM1
assembles Orai proteins into open CRAC channels within these puncta at ER-PM junctions,
thereby mediating Ca2+ influx from the extracellular space.
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Figure 1.3. Schematic diagram of the SOCE molecular activation mechanism.
Decreases of ER luminal Ca2+ levels initiates EFSAM oligomerization. Oligomerization
promotes rearrangement of the coiled-coil domains that promotes translocation of STIM1
to ER-PM junctions. The STIM1 puncta at ER-PM junctions recruit Orai1 to the same sites,
assembling and opening CRAC channels that promote cytosolic Ca2+ influx down a steep
concentration gradient from the extracellular space that contains high Ca2+ into the cytosol.
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1.4 STIM1 luminal domain
1.4.1 STIM1 luminal domain structure
The STIM1 luminal domain has conserved EF-hand and SAM domains close in
sequence space that fold cooperatively into a single globular domain. Therefore, this region
is also known as the EFSAM domain of STIM1. The EFSAM domain is highly conserved
from lower to higher functioning eukaryotes. The human STIM1 EFSAM domain includes
residues 63 to 201 and consists of a canonical Ca2+ binding EF-hand (cEF) motif, a noncanonical EF-hand (nEF) motif and a SAM domain. Stathopulos and his colleagues
discovered that an EFSAM mutant consisting of residues 58 to 201 contained a high fraction
of α-helical secondary structure in the presence of Ca2+ and showed a well-dispersed 1H-15N
heteronuclear single quantum coherence (HSQC) spectrum, indicative of a well-folded
protein (Stathopulos et al., 2006, 2008).
Based on primary sequence, the cEF motif was identified as the only EF-hand in
STIM1 because of a conventional helix-loop-helix motif characteristics and the appropriate
negatively charged residues in the loop (Kretsinger & Nockolds, 1973). However, the high
resolution 3D structure solved by solution nuclear magnetic resonance (NMR) revealed that a
second EF-hand was present in EFSAM (Stathopulos et al., 2008). This was an important
discovery since the cEF was considered to be functioning as a stand-alone Ca2+ binding
domain (Williams et al., 2001; Roos et al., 2005; Liou et al., 2005; Zhang et al., 2005; Baba
et al., 2006; Mercer et al., 2006) prior to the elucidation of the EFSAM structure.
Furthermore, it was found that one important role of the nEF motif is to stabilize cEF through
backbone hydrogen (H)-bonding between the loop regions of each motif, creating a small βsheet as observed in other conventional cEF pairs such as calmodulin (CaM) (Ikura et al.,
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1985; Stathopulos et al., 2008). CaM is made up of two EF-hand domains linked through a
flexible linker, and each of these domains is made up of two cEF motifs (Ikura et al., 1985;
Chin & Means, 2000). Ca2+-loaded CaM has interhelix EF-hand angles of 81.4° and 107.7°
indicative of an “open” EF-hand motif conformation; the cEF (α1-β1-α2) and nEF (α3-β2α4) of EFSAM also adopt this “open” conformation with approximately perpendicular
interhelix angles of ~80° and 96.7° (Stathopulos et al., 2008). This feature of EF-hand
domains results in the formation of a hydrophobic pocket that promotes interactions with
target proteins. In the case of EFSAM, the SAM domain intramolecularly interacts with this
extensive hydrophobic area created by the STIM1 EF-hand pair (Stathopulos et al., 2008).
There is a cooperative interaction between the STIM1 EF-hand and SAM domains of
STIM1 (Figure 1.4). The EF-hand domain is linked to the SAM domain with a short helix
(α5), and the SAM domain consists of five helices (α6-α10) folded in a five-helix bundle
(Stathopulos et al., 2008). The hydrophobic pocket created by cEF and nEF allows the α10
helix of the SAM domain to tightly pack into this pocket forming a compact globular shape
overall (Stathopulos et al., 2008). Thus, the EF-hand and SAM domains are not only linked
in sequence space through α5, but they also interact through regions that are distant in
sequence space. The intramolecular interaction between EF-hand and SAM domain is an
important structural feature that plays an essential role in the regulation of STIM1 activation
and function in the SOCE pathway.
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Figure 1.4. Depiction of the backbone structure of the Ca2+-loaded EFSAM domain.
The EF-hands are coloured blue, the SAM domain is coloured green and the short linker
helix is coloured yellow. Ca2+ is represented as a black sphere; N, amino terminus; C,
carboxy terminus. The two asparagine residues, Asn131 and Asn171, are highlighted as red
and magenta sticks, respectively. The Asn131 and Asn171 residues undergo N-linked
glycosylation (see below).
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1.4.2 Biophysical properties of STIM1 luminal domain
The initial step of the SOCE pathway starts with the depletion of ER Ca2+ levels.
Under resting ER Ca2+ levels, the STIM1 luminal EFSAM domain is bound to Ca2+
(Stathopulos et al., 2006; Stathopulos & Ikura, 2013b). With the cEF coordinating Ca2+, the
EF-hand and SAM domains are well folded, forming the stable and compact monomeric
conformation within STIM1 described above (Stathopulos et al., 2006, 2008). However, in
the absence of Ca2+, this region loses a large fraction of its α-helicity and is drastically
destabilized (Stathopulos et al., 2006, 2008). Dissociation of Ca2+ from the cEF binding site
triggers an EFSAM unfolding event. This partial protein unfolding is coupled with a
decreased stability and results in oligomerization of the STIM1 luminal domains. The
EFSAM oligomers are polydisperse, consisting of dimers and larger order oligomers. STIM1
oligomerized through the luminal domains results in a rearrangement of the cytosolic
domains, oligomerization of the CC regions and translocation to the ER-PM junctions,
establishing puncta. Thus, luminal EFSAM STIM1 oligomerization is the initiation event that
leads to STIM1 translocation, recruitment and gating of Orai1 channels at ER-PM junctions,
resulting in open CRAC channels on the PM ( Zhang et al., 2005; Stathopulos et al., 2006,
2008; Liou et al., 2007).
Assessment of EFSAM Ca2+ binding using a

45

Ca2+ equilibrium ultrafiltration

procedure and positive electrospray ionization mass spectrometry revealed a single low
affinity Ca2+ binding site with an equilibrium dissociation constant (Kd) of ~200-600 µM
(Stathopulos et al., 2006; Huang et al., 2009; Zheng et al., 2011). Furthermore, this Kd range
is consistent with the physiological range of Ca2+ concentrations found in the ER lumen,
suggesting that the EFSAM Ca2+ binding property is optimized to the Ca2+ fluctuations of the
lumen for the regulation of SOCE.
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1.5 N-glycosylation of STIM1
In eukaryotes, most proteins undergo post-translational modifications for an added
layer of protein regulation and selective participation in cellular processes (Walsh et al.,
2005; Boscher et al., 2011). A common modification is glycosylation where there is an
attachment and processing of oligosaccharide structures, also known as glycans, through
various biosynthetic steps in the ER and Golgi (Dennis et al., 2009; Nilsson et al., 2009;
Stanley, 2011). The process of glycosylation can distinctly be separated into two types: Nlinked and O-linked glycosylation based on specific amino acid and linkage it forms.

1.5.1 N-linked glycosylation
In N-linked glycosylation, glycans are attached to the side chain amide of asparagine
(Asn), and in most cases, the initiation step occurs in the ER as the polypeptide chain moves
into the lumen and is still being translated outside the membrane; therefore, it is sometimes
considered a co-translational modification (Gerlach et al., 2012). On the other hand, O-linked
glycosylation refers to the addition of glycans on the side chain hydroxyl group of serine or
threonine residues, and this modification occurs entirely after translation in the Golgi
complex (Gerlach et al., 2012). The consensus amino acid sequence needed in the nascent
polypeptide chain for N-linked modification is Asn-X-Ser/Thr/Cys, where X can be any
amino acid except proline. When this sequence is recognized, the first step is the transfer of a
fourteen-sugar structure made up of glucose (Glc), mannose (Man), and N-acetylglucosamine
(GlcNAc) (i.e., Glc3Man9GlcNAc2) from an ER membrane lipid by oligosaccharyltransferase
(Pearse & Hebert, 2010; Stanley et al., 2014). Further steps, such as cleavage or transfer of
glucose residues, are catalyzed in the ER by specific glycosidases and glycosyltransferases.
During modification in the ER, there are specific proteins such as UDP-glucose:glycoprotein
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glucosyltransferase, that monitor proper protein folding upon glucose cleavage prior to
further modification steps (Gerlach et al., 2012). Some proteins that are properly folded
successfully leave the ER and move into the Golgi, and in the Golgi, a mannose subunit is
removed to generate Man8GlcNAc2 to prevent further glucosylation (Avezov et al., 2008).

1.5.2 N-glycosylation of EFSAM
Examination of the EFSAM primary amino acid sequence reveals two consensus Nlinked glycosylation sites: Asn(residue 131)-Trp-Thr and Asn(residue 171)-Thr-Thr (Figure
1.2). Further, previous studies have indeed shown that the EFSAM domain can be Nglycosylated on Asn131 and Asn171 (Williams et al., 2002; Csutora et al., 2008; Kilch et al.,
2013). The first study by Williams and colleagues (Williams et al., 2002) found that a
fraction of STIM1 is localized to the PM, where the EFSAM domain is oriented in the
extracellular space. Furthermore, they discovered that inhibition of N-glycosylation using
tunicamycin prevented STIM1 localization to the PM. Williams and coworkers also showed
that both N-linked glycosylation of Asn131 and Asn171 were endoglycosidase H (endoH)sensitive (Williams et al., 2002). EndoH is an enzyme that digests glycans and is commonly
used to study N-glycosylated proteins. EndoH cleaves the chitobiose core dimer of β-1,4linked GlcNAc in high mannose and some hybrid oligosaccharides that are modified in the
Golgi, but is unable to cleave fully Golgi processed proteins with complex glycans.
Therefore, the findings by Williams et al., on the endoH sensitivity of STIM1 indicates the
immature modification and the absence of full terminal processing in the Golgi is sufficient
for cell surface expression of STIM1 (Williams et al., 2002). Other STIM1 glycosylation
studies by Csutora and Kilch and coworkers will be discussed below.
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1.6 Rationale, hypothesis, and objectives
1.6.1 Rationale and hypothesis
While it is established that STIM1 has two N-glycosylation sites within the ER
luminal region (i.e., the Asn131 site located in the short linker α-helix between the EF-hand
and SAM domain and the second Asn171 site located within the SAM domain) the precise
effect of N-glycosylation on the activation and function of STIM1 is unknown. Further, there
are several ambiguous and inconsistent observations in the available literature on how Nglycosylation may affect SOCE (Mignen et al., 2007; Csutora et al., 2008; Czyz et al., 2009;
Kilch et al., 2013). A study by Czyz and colleagues found SOCE activity is enhanced in
tunicamycin treated Jurkat cells. Tunicamycin inhibits endogenous glycosylation of all
proteins; moreover, measurement of cytosolic Ca2+ concentrations with fura2 showed
enhanced SOCE in tunicamycin treated Jurkat cells (Czyz et al., 2009). In a separate study,
Kilch and colleagues, mutated the Asn131 and Asn171 of STIM1 to aspartic acid and
glutamine (Gln), respectively, and found enhanced SOCE (Kilch et al., 2013). However,
when they mutated both residues to Gln, SOCE was abolished. Mignen et al., also studied the
effect of Asn to Gln double mutations in STIM1, but in contrast to the Kilch et al., study they
found that the Asn131Gln/Asn171Gln double mutant had no effect on CRAC channel
function using electrophysiological measurements (Mignen et al., 2007). On the other hand,
work done by Csutora and coworkers showed that the Asn131Gln/Asn171Gln STIM1 double
mutant inhibits SOCE (Csutora et al., 2008). Csutora et al., transfected the double mutant
STIM1 into neuronal NG115 cells that endogenously express very low levels of STIM1 and
found that SOCE was suppressed compared to the wild-type STIM1-mediated process
(Csutora et al., 2008).
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The published inconsistencies on how STIM1 N-glycosylation affects STIM1
function reveal a pressing need to study the precise effect of glycosylation on EFSAM at the
molecular and atomic levels. Since the initiation of the STIM activation process is entirely
dependent on the EFSAM domain, a comparison of the structural, biophysical and
biochemical changes caused by glycosylation of EFSAM should reveal how this
modification affects STIM1 regulation of SOCE. Therefore, my thesis work focuses on how
glycosylation affects the Ca2+ sensing properties of STIM1 EFSAM. I hypothesize that
glucose conjugation to the STIM1 EFSAM domain at the Asn131 and/or Asn171 sites (i.e.,
neo-glycosylation) will alter the molecular properties of EFSAM as well as normal SOCE
regulation.

1.6.2 Objectives
Aim 1: To express and purify recombinant wild type and mutant EFSAM proteins for sitespecific neo-glycosylation.
I mutated Asn131 and Asn171 to cysteine (Cys) within an EFSAM recombinant expression
vector to enable an enzyme-free in vitro approach for site-specifically controlling
modifications at these sites. Cysteine residues have a thiol group that allows
methanethiosulfonate-derivatized glucose to be covalently attached to the protein via
disulfide bond formation. Glucose conjugation to the protein in this manner mimicked
endogenous glycosylation with respect to the proximity of a glucose moiety close to the
surface of the protein.

Aim 2: To study the effect of neo-glycosylation on the structure, stability, oligomerization,
and Ca2+ binding properties of the EFSAM domain.

22

STIM1 structure is highly dynamic and its biophysical properties are intimately linked to its
activation. Therefore, examining the neo-glycosylation-induced changes in structure,
stability, oligomerization and Ca2+ binding affinity provides a better understanding of the
mechanisms by which glycosylation regulates STIM1 activity and the SOCE pathway.

Aim 3: To examine the role of Asn131 and Asn171 glycosylation in STIM1 activated SOCE
using HEK293 mammalian cell culture.
I overexpressed mCh-tagged STIM1 with Asn131Gln, Asn171Gln or Asn131Gln/Asn171Gln
mutations in HEK293 cells that were stably expressing YFP-Orai1. The mutations to Gln
were engineered to block endogenous glycosylation at these sites within STIM1 without
dramatically altering the polypeptide properties due to the similar nature of the Asn and Gln
side chains. HEK293 mammalian cells are a good model system because this cell line
expresses little or no STIM1 and Orai1 (Williams et al., 2001; Roos et al., 2005; Dehaven et
al., 2007). The STIM1 activated cytosolic Ca2+ uptake in response to ER-luminal Ca2+
depletion by TG was studied using a fura2 ratiometric fluorescence approach.
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Chapter 2
Methods
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2.1 Constructs and Mutations
The human STIM1 Ca2+ sensing domain corresponding to residues 58-201 was
expressed in Escherichia coli using the previously described pET-28α-EFSAM vector
(Stathopulos et al., 2006). The two asparagine residues (i.e., Asn131 and Asn171) were
mutated to cysteines with High-Fidelity PCR polymerase (Thermo Scientific, Inc.), and
mutagenic primers (Table 2.1). Two separate PCR mixtures, each with forward or reverse
primers, were prepared and templates were amplified according to a 10-cycle mutagenesis
program (Table 2.2). When 10 cycles were complete, the two separate PCR reactions were
immediately mixed and amplified 25 additional cycles, using the same program (Table 2.2).
After amplification was completed, the template vector was digested using DpnI (New
England BioLabs, Inc.) for 2 h at 37 °C. The amplified DNA was subsequently transformed
by heat shock into competent E. coli DH5α to repair the nicks and propagate the plasmid.
Colonies harboring the mutated pET-28α-EFSAM plasmid were selected on kanamycincontaining agar plates. After two single mutations had been engineered (i.e., Asn131Cys and
Asn171Cys), the pET-28α-EFSAM-Asn131Cys was used as template to generate a cDNA
containing the double mutation (i.e., Asn131Cys/Asn171Cys).
For mammalian cell protein expression, the previously described pCMV6 vector
encoding full-length human STIM1 (i.e., residues 1-685) with mCh fused just after the ER
signal peptide (i.e., residue 1-23) was used (Stathopulos et al., 2008). The Asn131 and
Asn171 residues were mutated to glutamine in the pCMV6-mChSTIM1 vector using the
same mutagenesis approach as described above and the mutagenic primers described in
(Table 2.1). Colonies harboring the mutated pCMV6-mChSTIM1 plasmid were selected on
ampicillin-containing agar plates. The double Asn131Gln/Asn171Gln mutation was also
engineered using the pCMV6-mChSTIM1-Asn131Gln vector as a template.
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Table 2.1. Primers used for mutagenesis and sequencing. All primers were synthesized
by Sigma-Aldrich (St. Louis, MO).
Primer
EFSAM
Asn131Cys a

EFSAM
Asn171Cys a

STIM1
Asn131Gln b

STIM1
Asn171Gln b
T7 terminator c
STIM1 c

Nucleotide Sequence
5’-GTCATCAGAAGTATACTGTTGGACCGTGGATGAGG-3’
3’-CAGTAGTCTTCATATGACAACCTGGCACCTACTCC-5’
5’-CCAAGGCTGGCTGTCACCTGCACCACCATGACAGGG-3’
3’-GGTTCCGACCGACAGTGGACGTGGTGGTACTGTCCC-5’
5’-GTCATCAGAAGTATACCAGTGGACCGTGGATGAGG-3’
3’-CAGTAGTCTTCATATGGTCACCTGGCACCTACTCC-5’
5’-CCAAGGCTGGCTGTCACCCAAACCACCATGACAGGG-3’
3’-GGTTCCGACCGACAGTGGGTTTGGTGGTACTGTCCC-5’
5'-GCTAGTTATTGCTCAGCGG-3'
5’-AGCTCGGGGGCCAACTCTGAGGAG-3’

aMutagenesis

primer for pET-28α
primer for pCMV6-XL5-mCh-STIM1
cSequencing primers
bMutagenesis
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Table 2.2. PCR amplification template on LifeECO (Bioer)

10-Cycles

pCMV6
parameters

25-Cycles

25-Cycles

Temp
(°C)

Time

Temp
(°C)

Time

Temp
(°C)

Time

98.0

35 s

98.0

35 s

98.0

30 s

Denaturation

98.0

10 s

98.0

10 s

98.0

10 s

Annealing

56.5

30 s

56.5

30 s

55.5

30 s

Extension

72.0

5 min

72.0

5 min

72.0

3 min

72.0

5 min 30 s

72.0

5 min

4.0

Hold

4.0

Hold

Initial Denaturation

#-Cycles

pET-28α
parameters

Final Elongation
Storage

4.0

Hold
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All

mutant

pET-28α-EFSAM

constructs

(i.e.,

Asn131Cys,

Asn171Cys,

Asn131Cys/Asn171Cys) were verified by dideoxy sequencing using the T7 reverse
terminator

primer

(Table

2.1)

at

the

Robart’s

DNA

Sequencing

facility

(http://www.robarts.ca/london-regional-genomics-centre). Successful mutagenesis of the
pCMV6-mChSTIM1 constructs (i.e., Asn131Gln, Asn171Gln, Asn131Gln/Asn171Gln) was
verified using an in-house designed primer (Table 2.1) and sequenced at the Robart’s DNA
Sequencing facility.

2.2 Protein expression and purification
2.2.1 Protein expression
pET-28α-EFSAM (i.e., wild-type, Asn131Cys, Asn171Cys, Asn131Cys/Asn171Cys)
were separately transformed into E. coli BL21 ΔE3 codon (+) competent cells and plated on
kanamycin resistant Luria broth (LB) agar plates. A single colony was picked and
subsequently cultured in 1 L of LB medium supplemented with 60 µg/ml kanamycin at 37 °C
and ~190 rpm, until the optical density at 600 nm (OD600) reached 0.6-0.8. Subsequently, 200
µM of isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to induce protein
expression. After IPTG addition, the cells were incubated at ambient temperature overnight
with constant shaking. Bacteria were harvested by centrifugation in a J2-21M Induction drive
centrifuge (Beckman, Inc.) with JA10 rotor at 7250 rpm, 4 °C for 25 min, and the cell pellet
was collected and stored at -80 °C until purification.
For uniformly

15

N-labelled EFSAM proteins used in the solution NMR experiments

(see below), bacterial cells were grown in M9 minimal media salts (i.e., 42.2 mM of
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Na2HPO4 anhydrous, 22.0 mM of KH2PO4, 8.6 mM of NaCl, pH7.4 in 1 L) supplemented
with a 0.2 µm filtered mixture of 0.2% w/v D-glucose, 100 µM CaCl2, 50 µM thiamine,
1 mM MgSO4, 1 mg/L biotin, 1 g/L

15

N-NH4Cl labeling, and 60 µg/ml kanamycin. Cell

growth, IPTG induction, cell harvesting and purification (see below) were exactly as
described for LB broth (see above).

2.2.2

Protein purification
Since EFSAM formed inclusions due to the low intracellular Ca2+ levels of E. coli,

the frozen bacterial cell pellet was manually homogenized in 6 M guanidine-HCl and 20 mM
Tris-HCl (pH 8), to resolubilize the aggrepated protein. Approximately 30 mL of guanidineHCl was added per 5 mL of wet cell pellet. Subsequently, the mixture was incubated for 90
min at ambient temperature with constant rotation in a hybridization oven. The homogenized
mixture was subsequently centrifuged in J2-21M Induction drive centrifuge (Beckman, Inc.)
with JA10 rotor at 7500 rpm, 8 °C for 40 min to separate the insoluble cell debris (pellet)
from the soluble protein mixture (i.e., supernatant). 750 µL of a 50% (v/v) Ni-Nitrilotriacetic
acid agarose bead slurry (Qiagen, Inc.) was added to the clarified lysate (~30 mL) and
incubated for another 90 min at room temperature by inversion in a hybridization oven.
Subsequently, the beads with captured 6×His-tagged proteins were collected in a gravity flow
protein purification column and washed 3 times with 10 mL of 6 M urea with 20 mM TrisHCl pH 8 and 5 mM β-mercaptoethanol for the mutant proteins. The proteins were eluted in
7 2-ml fractions using 6 M urea, 20 mM Tris-HCl pH 8, 300 mM imidazole, and 5 mM βmercaptoethanol for the mutant proteins (Figure 2.1A). The eluted protein fractions were
pooled into a dialysis membrane with a 3500 Da molecular weight cutoff (BioDesign Inc.)
and incubated in 1 L refolding buffer (Table 2.3) at 4°C overnight.
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Figure 2.1. SDS-PAGE gel analyses of STIM1 EFSAM purification. (A) Wild-type
6×His-EFSAM (~19 kDa) protein elution fractions from Ni-NTA beads. (B) Migration of
wild-type EFSAM before (~19 kDa) and after (~17 kDa) 6×His thrombin digestion. The
gels in (A) and (B) were 15 % (v/v) stained with Coomassie blue, and the molecular
weight marker migration is shown at the leftmost lane of each gel.
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Table 2.3. Components of the experimental buffers used in the thesis research.

Refolding buffer

20 mM Tris-HCl pH 8.0, 150 mM NaCl,
5 mM CaCl2, 1 mM dithiothreitol (DTT) for
mutants

Ion Exchange Buffer A

20 mM Tris-HCl pH 8, 5 mM CaCl2,
1 mM DTT for the mutants

Ion Exchange Buffer B

20 mM Tris-HCl pH 8, 1 M NaCl, 5 mM CaCl2,
1 mM DTT for the mutants

Ca2+-loaded

buffer

Ca2+-free buffer
Modification Buffer

20 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM
CaCl2, 1 mM tris(2-carboxyethyl)phosphine
(TCEP) for non modified mutants
20 mM Tris-HCl pH 7.5, 150 mM NaCl,
1 mM TCEP for non-modified mutants
20 mM 3-(N-morpholino)propanesulfonic acid
(MOPS) pH 8.3, 150 mM NaCl, 5 mM CaCl2,
0.1 mM TCEP

Modified Ca2+-loaded buffer

20 mM Tris-HCl pH 7.5, 150 mM NaCl,
5 mM CaCl2

Modified Ca2+-free buffer

20 mM Tris-HCl pH 7.5, 150 mM NaCl
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After overnight refolding, approximately 1 U of thrombin (BioPharm Laboratories, Inc.) per
mg of protein was added directly to the dialysis bag and incubated again at 4 °C overnight.
Successful cleavage of 6×His tag was verified by a shift in the migration of the protein
visualized by Coomassie-blue staining of denaturing polyacrylamide gels, after
electrophoresis (Figure 2.1B). 100 µM of 4-(2-Aminoethyl) benzenesulfonyl fluoride
hydrochloride (AEBSF) was added before further purification to inhibit thrombin and other
proteases until further purification.

2.2.3 Anion Exchange chromatography
Anion exchange chromatography was used to further purify the EFSAM proteins,
with an increasing NaCl gradient (Buffer B). Protein solutions were concentrated
approximately 10-fold then re-diluted in a NaCl-free (Buffer A) (Table 2.3). Protein was
manually loaded onto a HiTrapTM Q FF anion exchange column (GE Healthcare, Inc.) using
a 10 mL syringe. Proteins were eluted in a gradient [i.e., 0 – 60 % (v/v)] of increasing Buffer
B (Table 2.3) (Figure 2.2A). Ion exchange elution fractions were assessed for purity using
Coomassie blue-stained SDS-PAGE gels (Figure 2.2B). Fractions with purity of > 95 % were
pooled and exchanged to Ca2+-loaded buffer (Table 2.3) using a Vivaspin20 centrifugal
concentrator (Sartorius, Inc.).

2.2.4 Preparation of Ca2+-free apo protein samples
To prepare Ca2+-free (i.e., apo) protein samples, 25 mM of ethylenediamine
tetraacetic acid (EDTA) was added to the sample and incubated overnight at 4 °C. Samples
were concentrated to ≤1 mL and diluted in the buffer of interest, Ca2+-free buffer (Table 2.3),
to ~20 ml and re-concentrated to 1 mL using Vivaspin20 exchanger (Sartorius, Inc.). This
process was repeated three times for a 20×20×20-fold exchange.
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Figure 2.2. Anion exchange chromatographic separation of wild-type EFSAM
protein. (A) Anion exchange chromatogram of wild-type EFSAM in an increasing NaCl
gradient [i.e., 0 to 60 % (v/v)]. The blue line represents the UV absorbance at 280 nm
and the red line represents the % (v/v) gradient of 1 M NaCl. (B) Coomassie blue stained
SDS-PAGE gel [15 % (v/v)] of the wild-type EFSAM elution fractions shown in (A).
The leftmost lane shows the molecular weight marker migration.
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2.3 Neo-glycosylation of EFSAM
The protein sample was exchanged into the modification buffer (Table 2.3) using the
same exchange approach mentioned above (2.2.4). A 55 mM stock solution of N-(β-Dglucopyranosyl)-N’-[2-methanethiosulfonyl)ethyl]urea (MTS-5-glucose) (Toronto Research
Chemicals, Inc.) was prepared in dimethylsulfoxide (DMSO). A final concentration of 2 mM
MTS-5-glucose was added to ~60 µM protein samples and incubated in the dark for 1 h at
ambient temperature with mixing by gentle tapping of the microfuge tube every 10 min.
Subsequently, the protein was re-exchanged into the final modified Ca2+-loaded buffer using
a Vivaspin20 centrifugal concentrator (Sartorius, Inc.). Modified apo protein samples were
prepared exactly as described for the Ca2+ loaded samples, using however, the modified Ca2+free buffer shown in Table 2.3. The glucose conjugation to the protein is termed neoglycosylation in this thesis; therefore, modified EFSAM proteins are referred to as neoglycosylated EFSAMs.
To validate the modification protocol, I performed electrospray ionization mass
spectrometry on the Asn171Cys EFSAM protein sample which I was able to obtain at the
highest yield, compared to all the mutant EFSAMs studied. The unmodified Asn171Cys
mutant has a theoretical mass of 17,346.38 Da, and the MTS-5-glucose compound has a mass
of 360.40 Da. Upon successful modification, the expected mass of gl-Asn171Cys protein
(MTS-5-glucose modification represented as gl) is 17,626.67 Da [i.e., 17,346.38 – H+ (1.01)
+ 360.40 – CH3SO2 (79.10)]. The modified gl-Asn171Cys sample was exchanged into 20
mM ammonium bicarbonate and 2 mM CaCl2, pH 8 using the dialysis method. The prepared
sample was sent to the Biological Mass Spectrometry Laboratory in London Regional
Proteomic Centre (http://www.uwo.ca//biochem/lrpc/LRPC.html). The mass spectrum
revealed the bulk of the protein had a mass of 17,628.05 Da, which was within 1.4 Da of the
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expected theoretical mass for the glucose modified Asn171Cys protein (i.e., gl-Asn171Cys)
(Figure 2.3). Importantly, no detectable unmodified Asn171Cys protein was observed in the
spectrum above the baseline level, confirming a highly efficient modification procedure. The
relatively large intensity peak observed at 17,380.78 Da corresponds to +34 Da or -247 Da
compared to the unmodified and modified protein, respectively, and so the identity of this
peak could not be reliably inferred. After validation of the modification protocol by this mass
spectrometry experiment, a similar procedure was used to modify the Asn131Cys and
Asn131Cys/Asn171Cys proteins; additional confirmation of the modification was obtained
by solution NMR, which gave no indication of peak doubling associated with partial
modification.
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Figure 2.3. Positive ionization electrospray mass spectrum of glucose conjugated
Asn171Cys EFSAM protein. Approximately 57 nM of protein was exchanged in 20
mM ammonium bicarbonate and 2 mM CaCl2, pH 8. The mass spectrometry measured
mass of gl-Asn171Cys was within 1.4 Da of the expected theoretical mass; Asn171Cys
+ gl = 17,346.38 + 280.40 = 17,626.78.
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2.4 Far-UV circular dichorism (CD) spectroscopy
A Jasco-J-810 Spectrometer equipped with a Jasco PTC-423S temperature controller
was used to measure the far-UV CD spectra for samples prepared at 1 mg/mL in the presence
and the absence of 5 mM CaCl2. A 0.01 cm pathlength quartz cuvette was used to acquire the
CD spectra. Spectra were collected at 4 °C between 250 nm to 190 nm, with a scanning
speed of 20 nm/min, response time 8 s, an average of 3 accumulations and 1 nm data pitch.
Protein spectra were corrected for buffer contributions.

2.4.1 Thermal stability using far-UV CD spectroscopy
Thermal stabilities were taken from the change in ellipticity at 225 nm as a function
of temperature. For these thermal melts, a 0.1 cm pathlength quartz cuvette was used with
protein concentrations of ~0.5 mg/mL. The temperature was increased from 4 °C to 75 °C at
1 °C/min and data were collected with an 8-s response time, and 1°C data pitch. From the
spectrum, the apparent midpoint of temperature denaturation (Tm) was determined using the
Boltzmann sigmoid equation:
𝑌=

𝑀𝑖𝑛 + (𝑀𝑎𝑥 − 𝑀𝑖𝑛)

(1 + 10

!"#$%!𝒳 ∙!"#$%

)

where Y is the change in CD signal, Min represents the bottom plateau, Max represents the
top plateau, and 𝒳 is the temperature.

2.4.2 Ca2+ binding affinity using far-UV CD spectroscopy
Ca2+ binding curves were constructed from the change in ellipticity at 225 nm as a
function of changing CaCl2 concentrations. For these binding curves, a 0.1 cm pathlength
quartz cuvette was used with apo protein samples at 0.5 mg/mL. The far-UV CD spectra
were acquired at 4 °C from 250 nm to 200 nm, with a scanning speed of 20 nm/min, response
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time of 8 s, an average of 3 accumulations and 1 nm data pitch. A spectrum was acquired
after the addition of fourteen CaCl2 titration points between 0 and ~16 mM CaCl2. The
spectral intensities were corrected for the dilution associated with the volume change caused
by the addition of each aliquot of CaCl2. Ca2+ binding curves were fit and the fitted apparent
equilibrium dissociation constant (Kd) was determined using a one site-binding model that
takes into account protein concentration:
𝑃 + 𝐶𝑎

!"

𝑃𝐶𝑎, 𝑃𝐶𝑎 = ½[𝐾𝑑 + 𝑃𝑡𝑜𝑡 + 𝐶𝑎 −

𝐾𝑑 + 𝑃𝑡𝑜𝑡 + 𝐶𝑎

!

− 4𝑃𝑡𝑜𝑡 ∙ 𝐶𝑎]

where P is the free protein, Ca is the free Ca2+, PCa is the bound protein, and Ptot is the total
protein concentration.

2.5 Solution NMR spectroscopy
Approximately 100-200 µM of protein solubilized in 20 mM Tris, 150 mM NaCl, pH
7.5 was supplemented with 60 µM of 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) and
10 % D2O (v/v) in a final volume of 600 µL. The samples were loaded into a 5 mm NMR
tube. 1H-15N HSQC spectra (Kay et al., 1992; Farrow et al., 1994) were obtained at 25 °C on
a Varian Inova 600 MHz NMR spectrometer equipped with a triple resonance HCN
cryogenic probe. The number of transients was set to 256, and the number of increments in
the nitrogen dimension was set to 64 for all the samples. The 1H and 15N sweep widths were
8,000 and 1,800 Hz, respectively. All NMR spectra shown were chosen based on the highest
signal to noise given for each sample group: Wild-type (n=2), Asn131Cys and gl-Asn131Cys
(n=3), Asn171Cys and gl-Asn171Cys (n=4), Asn131Cys/Asn171Cys and gl-Asn131Cys/glAsn171Cys (n=2). The neo-glycosylated spectra were compared to the unmodified spectra by
supplementing the samples with 15 mM DTT to fully remove the glucose moiety by
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reduction. Total chemical shift perturbations (CSP) were calculated from the chemical shift
differences observed in the

15

N and 1H dimensions of each peak and normalizing for the

larger 15N chemical shift range using the following equation:
𝐶𝑆𝑃 =

[∆𝐻! + 0.14 ∙ ∆𝑁 ! ]

where ΔH is the ppm change in proton dimension, and ΔN is the ppm change in the nitrogen
dimension.

2.6 Static Light Scattering (SLS)
Stock protein samples were centrifuged at 8,500 g for 5 min at 4 °C to remove any
pre-exiting aggregates and precipitates. After measuring protein concentration using
absorbance at wavelength 280nm and an extinction coefficient of 1.6062, samples were
diluted to a concentration 0.2 mg/mL in the appropriate Ca2+-loaded buffers (Table 2.3). 100
µL of 0.2 mg/mL protein samples were subsequently centrifuged in a Legend Micro 21R
Centrifuge (Thermo Scientific, Inc.) at 15,000 g for 5 min at 4 °C. 25 µL of the supernatant
was aliquoted into a clean quartz MicroCuvette and the SLS intensity at 90 ° was measured
on a DynaPro Nanostar (Wyatt Technology) at 658 nm with the laser power attenuated to 10
%, for 6 consecutive measurements (10 s each) at 37 °C.
To assess the Ca2+-depletion-dependent oligomerization propensity, 50 mM EDTA
was added to the sample in the cuvette and mixed by pipetting. SLS intensity after the EDTA
addition was measured with the laser power attenuated to 10 % for 360 consecutive
measurements (i.e., 10 s each) at 37 °C. The 10 consecutive measurements that showed the
highest intensity were taken for statistical analysis. To assess the Ca2+-independent
oligomerization propensity, 100 µL of 0.2 mg/mL protein samples were centrifuged in a
Legend Micro 21R Centrifuge (Thermo Scientific, Inc.) at 15,000 x g for 5 min at 4°C.
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Subsequently, 80 µL of the supernatant was removed. The pellet was re-suspended in the
remaining 20 µL protein solution and 5 µL was used for the SLS measurements with the laser
power attenuated to 10 % at 37°C for 9 consecutive measurements (10 s each).

2.7 Live cell experiments
2.7.1 Cell culture
HEK293 cells stably expressing YFP-Orai1 were generously gifted by Dr. Monica
Vig from Washington University in St. Louis (St. Louis, MO) (Miao et al., 2013). Cells were
maintained at 37 °C in a 5% CO2/95% air humidified incubator in Dulbecco’s modified eagle
medium (DMEM) supplemented with 10 % (v/v) fetal bovine serum (Wisent, Inc.), 100
µg/ml penicillin-streptomycin, and 0.4 mg/ml G418 Disulfate (Fisher Scientific, Inc.).
HEK293-YFP-Orai1 cells were passaged at ~80% confluency using the following procedure.
First the cell culture medium was aspirated off the dish; subsequently, the adherent cells were
gently washed with 10 mL of warm phosphate buffered saline (PBS). After PBS removal by
aspiration, 1 mL trypsin/EDTA (Wisent, Inc.) was added per 10- cm plate, and the plate was
incubated for ~3 min at 37°C. 9 mL of warm culture medium with serum was used to inhibit
the trypsin and ~20-30% of the cell mixture was re-plated with fresh medium to 10 mL onto
a new plate.

2.7.2 Transfection
The cells were transfected at ~70-80% confluency in a 10-cm dish with PolyJetTM In
Vitro DNA transfection reagent (SignaGen Laboratories, Inc.) according to the
manufacturer’s instructions. 24 h before the experiment, the medium was replaced with 10
mL of fresh medium and the cells were cultured for 60 min at 37°C. 4 µg of DNA was mixed
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with 10 µL of the Polyjet reagent in 500 µL of DMEM high serum free and incubated at
room temperature for 15 min. The DNA/PolyJet mixture was then added to the cells
dropwise, and the cultures were incubated at 37 °C for an additional 24 h.
Transfection efficiency was calculated as the percentage of cells showing mCherry
Fluorescence, visualized on a Leica DMIRBE fluorescence microscope (Leica Microsytems,
Inc.) equipped with an Orca-ER digital camera (Hamamatsu Photonics, Inc.) and Volocity
4.3.2 software.

2.7.3 Fura2- ratiometric Ca2+ imaging
After confirming an ~80% transfection efficiency level, the cell medium was
aspirated and adherent cells were washed once with 5 mL per 10 cm dish of HBSS buffer
(140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl, 10 mM glucose, 10 mM 4-(2-hydroxyethyl)1-piperazineethanesulfonic acid (HEPES), pH 7.4) supplemented with 1.8 mM CaCl2. The
cells were subsequently collected after lifting by gentle pipetting with 3 mL of HBSS buffer
supplemented with 1.8 mM CaCl2, and 3 µM of fura2-AM (Alfa Aesar, Inc.), was added to
the 3 mL of suspended cells and incubated for 45 min in the dark at 37 °C. Subsequently, the
cells were diluted to 15 mL with HBSS buffer supplemented with 1.8 mM CaCl2 and
incubated for another 15 min in the dark at 37 °C. Next, the cells were washed 2× with HBSS
buffer supplemented with 1.8 mM CaCl2 by centrifuging at 1,000 x g for 6 min at room
temperature then aspirating the supernatant. The cells were finally washed with HBSS buffer
nominally free of CaCl2 and re-suspended in 1.2 ml of HBSS buffer. The final number of
cells in 1.2 mL of HBSS was ~5×106.
Fluorescence at 340 and 380 nm excitation and 510 nm emission was measured using
a Cary Eclipse spectrofluorimeter (Varian/Agilent, Inc.) equilibrated at 20°C, with a
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photomultiplier tube voltage of 700 V and slit widths at 5 and 10 nm. At 60 s, 0.5 µM of TG
and 0.1 mM EGTA were added. At 600 s, 0.5 mM of CaCl2 and at 900 s, an additional 3.5
mM of CaCl2 was added. The total experimental running time was 1500 s. Data were plotted
as a normalized F/F0 ratio to show relative changes in cytosolic Ca2+ levels, where F =
emission intensity ratio calculated using 340 nm/380 nm excitation wavelengths and F0 =
average F prior to the addition of TG, as has been done previously (Glitsch et al., 2002;
Jaiswal et al., 2009; Estrada et al., 2012; Tamouza et al., 2012; Chai et al., 2013; Fuchs et
al., 2013; Muller et al., 2015). Maximal changes in the fluorescence ratio after TG addition
was taken as the difference between the average of 11 consecutive intensity responses (i.e. 5
before and 5 after the highest intensity) and the average baseline F before TG addition.
Maximal changes after 0.5 mM CaCl2 addition and 3.5 mM CaCl2 were similarly calculated
compared to the baseline F intensity.
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Chapter 3
Results
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3.1 Double neo-glycosylated EFSAM constitutively loses αhelicity.
In the presence of Ca2+, EFSAM proteins show strong α-helical secondary structure
defined by negative ellipticity at ~208 and ~225 nm wavelengths in the far-UV circular
dichroism (CD) spectra (Figure 3.1A). Wild type EFSAM as well as the three mutants (i.e.,
Asn131Cys, Asn171Cys, Asn131Cys/Asn171Cys) show similar α-helicity based on far-UV
CD spectral shapes. Similarly, single modification of Asn131Cys or Asn171Cys minimally
perturbs the level of α-helicity in the presence of Ca2+. Remarkably, doubly modified glAsn131Cys/gl-Asn171Cys EFSAM displays less pronounced negative ellipticity at the 208
and 225 nm wavelengths, suggesting a loss of α-helical secondary structure.
To estimate the fraction α-helicity of each of the EFSAM variants, we used the online
web based tool DICHROWEB (Whitmore & Wallace, 2004). The CONTIN algorithm was
used to deconvolute α-helicity levels. The wild-type protein showed ~40% α-helicity, and all
the mutations and the single modified mutants showed comparable α-helicity levels (Figure
3.1C). However, the double glucose modified protein (i.e., gl-Asn131Cys/gl-Asn171Cys)
showed a significant reduction in α-helicity levels compared to wild-type EFSAM.
In the absence of Ca2+, modified and unmodified wild-type and mutant EFSAM
proteins showed a marked loss in the α-helical secondary structure (Figure 3.1B and 3.1C). A
qualitative assessment of the spectra shows less negative ellipticity at 208 nm and a major
loss of the ellipticity at 225 nm. A deconvolution of the percentage secondary structure using
the CONTIN algorithm in DICHROWEB revealed that all the modified and unmodified
EFSAM proteins show ~17 % α-helicity in the absence of Ca2+, significantly less than the
respective Ca2+-loaded states (Figure 3.1C). Overall, double glucose modification of EFSAM
results in a persistent partial loss of the α-helical secondary structure with or without Ca2+.
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Figure 3.1. Far-UV CD spectra of wild-type, Asn131Cys, Asn171Cys, Asn131Cys/
Asn171Cys, gl-Asn131Cys, gl-Asn171Cys, and gl-Asn131Cys/gl-Asn171Cys EF-SAM
proteins. (A) Ca2+ loaded EFSAM far-UV CD spectra. Spectra were acquired in 5 mM
CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, at 4°C. Unmodified and modified Ca2+ loaded
proteins were assessed in the presence and absence of 1 mM TCEP, respectively. (B) Ca2+
depleted EFSAM far-UV CD spectra. Spectra were acquired in 0.5 mM EDTA, 20 mM Tris,
150 mM NaCl, pH 7.5, at 4°C. Unmodified and modified Ca2+ depleted proteins were
assessed in the presence and absence of 1 mM TCEP, respectively. All the data in (A) and (B)
are the means ± SEM of n=3-4 separate protein preparations. (C) Percent α-helicity of the
proteins in the presence and absence of Ca2+. The percentages a-helicity were deconvoluted
from the spectra shown in (A) and (B) using DICHROWEB. The statistical evaluation was
two-way analysis of variance (ANOVA) with Bonferroni multiple comparisons test for data
in the presence of 5 mM CaCl2 and 0 mM CaCl2; *p<0.005, **p<0.0001.
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3.2 Neo-glycosylated EFSAM proteins are destabilized.
Tm was taken as a measure of protein stability and determined from the change in farUV CD signal at 225 nm as a function of temperature. In the presence of Ca2+, the Tm for the
wild-type EFSAM protein was ~ 48.5°C. All single and double mutants showed a significant
thermal destabilization compared to the wild-type control with Tm values ranging from
~42°C to 44°C (Figure 3.2A). Glucose conjugation of the single mutants marginally
destabilized EFSAM further by ~0.3-2.0°C; on the other hand, double glucose modification
at both the Asn131 and Asn171 sites (i.e., gl-Asn131Cys/gl-Asn171Cys) destabilized the
protein by a more marked ~3.7°C (Table 3.1). Thus, EFSAM stability is sensitive to
modifications at the Asn131 and Asn171 positions and glucose attachment close to the
surface of the protein enhances the destabilization.
In the absence of Ca2+, all protein samples were highly destabilized (Figure 3.2B).
Such a loss in stability is coupled to the pronounced decrease in α-helicity shown in Figure
3.1B. Since the Ca2+-depleted EFSAM proteins are in a persistently partially unfolded state,
only a small additional change in ellipticity occurred during thermal unfolding resulting in
considerable scatter in the data compared to the Ca2+-loaded proteins. Thus, we were unable
to reliably determine the Tm values in the absence of Ca2+. Nevertheless, it is clear that
glucose modified and unmodified Ca2+-depleted EFSAM proteins have a strikingly reduced
thermal stability compared to their Ca2+-loaded counterparts (Fig. 3.1A and 3.1B).
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Figure 3.2. Thermal stability of wild-type, Asn131Cys, Asn171Cys, Asn131Cys/
Asn171Cys, gl-Asn131Cys, gl-Asn171Cys, and gl-Asn131Cys/gl-Asn171Cys and
EFSAM proteins. (A) Thermal melts were acquired in 5 mM CaCl2, 20 mM Tris, 150
mM NaCl, pH 7.5. Stability was estimated from the change in far-UV CD signal at 225
nm as function temperature. Unmodified and modified Ca2+ loaded proteins were
assessed in the presence and absence of 1 mM TCEP, respectively. (B) Thermal melts
were acquired in 0.5 mM EDTA, 20 mM Tris, 150 mM NaCl, pH 7.5. Unmodified and
modified Ca2+ depleted proteins were assessed in the presence and absence of 1 mM
TCEP, respectively. Data in (B) was partially smoothed using three point averaging. All
data in (A) and (B) are the means ± SEM of n=3-4 separate protein preparations.
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Table 3.1. Summary of thermal stability changes for mutated and/or glucose modified
EFSAM proteins.
Proteins with Ca2+

Tm(°C) a

Wild-type

48.5 ± 0.18

Asn131Cys

44.0 ± 0.16*

- 4.5 ± 0.24

Asn171Cys

43.9 ± 0.09*

- 4.6 ± 0.20

Asn131Cys/Asn171Cys

41.5 ± 0.18*

- 7.0 ± 0.25

gl-Asn131Cys

42.0 ± 0.18*

- 6.5 ± 0.25

- 2.0 ± 0.24

gl-Asn171Cys

43.6 ± 0.09*

- 4.9 ± 0.20

- 0.3 ± 0.18

gl-Asn131Cys/gl-Asn171Cys

37.8 ± 0.14*

- 10.7 ± 0.23

- 3.7 ± 0.23

aT
m

ΔTm mut (°C) b

ΔTm mod (°C) c

using the Boltzmann’s fit. One-way ANOVA with Bonferroni multiple
comparisons test to the control group ‘wild-type’ was used for statistical analysis;
*p<0.0001.
bThe difference of all the other groups to T
m(Wild-type); Tm mut = Tm(mut/mod)-Tm(Wild-type)
cThe difference of T
to
that
of
T
m(unmodified)
m(modified); Tm mod = Tm(mod)-Tm(mut)
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3.3 Neo-glycosylation of EFSAM proteins causes local
structural perturbations.
I used solution NMR to assess structural perturbations caused by the EFSAM
modifications. Comparisons of the wild type with mutant and glucose-conjugated mutant
EFSAM protein 1H-15N-HSQC spectra reveal the changes in the backbone structures due to
modifications at the Asn131 and Asn171 sites. The wild-type EFSAM spectrum closely
matched the previously published spectrum for this protein which is ~80 % assigned
(Stathopulos et al., 2008) (BMRB accession number 15851), allowing the assignments to be
made by transference. Furthermore, reduced spectra with 15 mM DTT perfectly matched the
mutant spectra before the glucose modification, indicating that DTT addition to the neoglycosylated proteins fully reversed the modification process. I observed three CSP hotspots
caused by the Asn131Cys mutation (i.e., ~between residues 65-73, 121-142 and residues
156-170) (Figure 3.4A). Glucose-attachment to the Asn131Cys caused further CSPs largely
localized to these same areas relative to the primary sequence (Figure 3.4B). However, to
evaluate the overall structural perturbations caused by all the changes at the Asn131 site (i.e.,
mutation + glucose attachment) I compared the gl-Asn131Cys to the wild-type spectrum
(Figure 3.3) and calculated the CSPs (Figure 3.4C). I mapped the largest CSPs corresponding
to those greater than 1 and 2 standard deviation (SD) higher than the mean CSPs of all
residues on the wild-type EFSAM structure. While the three hotspots appear relatively
distant in sequence space, the perturbation map on the 3D structure revealed that the largest
CSPs were primarily localized to one face of the EFSAM domain within ~10 Å of the
Asn131Cys residue (Figure 3.5).
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Figure 3.3. 1H-15N HSQC spectrum of gl-Asn131Cys (magenta crosspeaks) overlaid
with the wild-type (black crosspeaks) spectrum. The spectra were acquired in 5 mM
CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, 20 °C at 600 MHz. The amides of residues
undergoing CSPs larger than the mean plus 1×SD due to the Cys mutation and the covalent
addition of the glucose moiety are labeled. The location of gl-Asn171Cys amide is
indicated with a red ellipse.
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Figure 3.4. Normalized CSPs derived from the 1H-15N HSQC spectra. (A)
Normalized CSPs calculated from the Asn131Cys EFSAM spectrum compared to the
wild-type EFSAM spectrum. (B) Normalized CSPs calculated from the gl-Asn131Cys
EFSAM spectrum compared to the Asn131Cys EFSAM spectrum. (C) Normalized CSPs
calculated from the gl-Asn131Cys EFSAM spectrum compared to the wild-type EFSAM
spectrum. In (A) – (C), the CSPs are shown relative to the STIM1 EFSAM residue
number, and the CSP levels of the mean (solid horizontal line) and the mean plus 1× and
2× the standard deviation (SD, broken horizontal lines) are shown. The relative location
of the STIM1 EFSAM secondary structure elements are shown at the top of panel (C)
with rectangles and arrows representing α-helical and β-strand elements, respectively.
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gl-Asn131Cys
Figure 3.5. The largest magnitude CSPs of gl-Asn131Cys relative to wild-type EFSAM
mapped on the 3D structure of wild-type EFSAM. The perturbations are shown as bluemagenta-white gradient on the backbone view of EFSAM where magenta indicates CSPs
greater than the mean plus 1×SD, and white indicates CSPs greater than the mean plus 2×SD.
The yellow sphere represents Ca2+. The structure image was rendered in PyMOL using
2K60.pdb.
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The Asn171Cys mutation resulted in two main CSP hotspots compared to wild-type
(i.e., between residues ~64-73 and ~165-190) (Figure 3.7A). The gl-Asn171Cys spectrum
showed further residue-specific CSPs in the same two regions, consistent with the attachment
of the glucose moiety (Figure 3.7B). The gl-Asn171Cys spectral changes compared to wildtype (Figure 3.6) were used to determine the CSPs caused by all the modifications at the
Asn171Cys site (Figure 3.7C). Similar to the gl-Asn131Cys protein, the two perturbation
hotspots caused by the gl-Asn171Cys that were separated by hundreds of residues in
sequence space localized to one face EFSAM within ~10 Å of the Asn171Cys site (Figure
3.8).
The spectrum obtained with the double mutant revealed three CSP hotspots between
residues ~65-79, ~121-135 and ~156-198 (Figure 3.10A). My glucose modification
procedure caused further residue-specific CPSs in these three hotspots, consistent with the
attachment of the glucose moiety to both the Asn131Cys and Asn171Cys sites (Figure
3.10B). While the Asn131Cys modification also caused three CSP hotspots (Figure 3.4C),
the double modification perturbed a broader range of residues in the SAM domain region,
consistent with the modification of the Asn171Cys. I calculated the overall CSPs from the
comparison of the gl-Asn131Cys/gl-Asn171Cys spectrum to wild-type spectrum (Figure
3.9). Again, while the three main CSP regions were separated in sequence space (Figure
3.10C), plotting the most perturbed residues on the 3D EFSAM structure revealed two
distinct clusters of structural changes (Figure 3.11). The first cluster was around the
Asn131Cys site and the second cluster surrounded to the Asn171Cys site.
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Figure 3.6. 1H-15N HSQC spectrum of gl-Asn171Cys (cyan crosspeaks) overlaid
with the wild-type (black crosspeaks) spectrum. The spectra were acquired in 5 mM
CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, 20 °C at 600 MHz. The amides of residues
undergoing CSPs larger than the mean plus 1×SD due to the Cys mutation and the
covalent addition of the glucose moiety are labeled. The location of gl-Asn171Cys
amide is indicated with a red ellipse.
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Figure 3.7. Normalized CSPs derived from the 1H-15N HSQC spectra. (A)
Normalized CSPs calculated from the Asn171Cys EFSAM spectrum compared to the
wild-type EFSAM spectrum. (B) Normalized CSPs calculated from the gl-Asn171Cys
EFSAM spectrum compared to the Asn171Cys EFSAM spectrum. (C) Normalized CSPs
calculated from the gl-Asn171Cys EFSAM spectrum compared to the wild-type EFSAM
spectrum. In (A) – (C), the CSPs are shown relative to the STIM1 EFSAM residue
number, and the CSP levels of the mean (solid horizontal line) and the mean plus 1× and
2× the standard deviation (SD, broken horizontal lines) are shown. The relative location
of the STIM1 EFSAM secondary structure elements are shown at the top of panel (C)
with rectangles and arrows representing α-helical and β-strand elements, respectively.
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gl-Asn171Cys

Figure 3.8. The largest magnitude CSPs of gl-Asn171Cys relative to wild-type EFSAM
mapped on the 3D structure of wild-type EFSAM. The perturbations are shown as bluegreen-white gradient on the backbone view of EFSAM where green indicates CSPs greater
than the mean plus 1×SD, and white indicates CSPs greater than the mean plus 2×SD. The
yellow sphere represents Ca2+. The structure image was rendered in PyMOL using
2K60.pdb.
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Figure 3.9. 1H-15N HSQC spectrum of gl-Asn131Cys/gl-Asn171Cys (orange
crosspeaks) overlaid with the wild-type (black crosspeaks) spectrum. The spectra
were acquired in 5 mM CaCl2, 20 mM Tris, 150 mM NaCl, pH 7.5, 20 °C at 600 MHz.
The amides of residues undergoing CSPs larger than the mean plus 1×SD due to the Cys
mutations and the covalent addition of the glucose moieties are labeled. The location of
gl-Asn131Cys and gl-Asn171Cys amides are indicated with red ellipses.
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Figure 3.10. Normalized CSPs derived from the 1H-15N HSQC spectra. (A)
Normalized CSPs calculated from the Asn131Cys/Asn171Cys EFSAM spectrum
compared to the wild-type EFSAM spectrum. (B) Normalized CSPs calculated from the
gl-Asn131Cys/gl-Asn171Cys EFSAM spectrum compared to the Asn131Cys/
Asn171Cys EFSAM spectrum. (C) Normalized CSPs calculated from the glAsn131Cys/gl-Asn171Cys EFSAM spectrum compared to the wild-type EFSAM
spectrum. In (A) – (C), the CSPs are shown relative to the STIM1 EFSAM residue
number, and the CSP levels of the mean (solid horizontal line) and mean plus 1× and 2×
the standard deviation (SD, broken horizontal lines) are shown. The relative location of
the STIM1 EFSAM secondary structure elements are shown at the top of panel (C) with
rectangles and arrows representing α-helical and β-strand elements, respectively.

Figure 3.11. The largest magnitude CSPs of gl-Asn131Cys/gl-Asn171Cys relative to wild-type EFSAM mapped on the 3D structure
of wild-type EFSAM. The perturbations are shown as blue-orange-white gradient on the backbone view of EFSAM where orange
indicates CSPs greater than the mean plus 1×SD, and white indicates CSPs greater than the mean plus 2×SD. The yellow sphere represents
Ca2+. The structure image was rendered in PyMOL using 2K60.pdb.
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Collectively, the structural analysis by solution NMR revealed successful site-specific
glucose attachment to both the single and double mutant EFSAM proteins. Additionally, the
CSPs revealed that the structural perturbations are localized to near the Asn131Cys or
Asn171Cys sites for the single modifications and appear to be largely additive for the double
mutant.

3.4 Neo-glycosylation lowers EFSAM Ca2+ binding affinity.
Kd values of Ca2+ binding were determined from the change in far-UV CD signal at
225 nm as a function of increasing Ca2+ concentrations (Figure 3.12A and 3.12B). Wild-type
EFSAM had the lowest Kd value (~0.18 mM) compared to all other EFSAM proteins,
indicating the highest Ca2+ affinity (Table 3.2). Mutation of Asn131 or Asn171 decreased the
Ca2+ binding affinity by ~1 order of magnitude. Glucose modification did not appreciably
alter these weakened affinities. Interestingly, the double mutation with or without the
modifications showed the weakest affinities compared to wild-type EFSAM.
A comparison of the structural changes associated with Ca2+ binding shows that wildtype EFSAM regains considerable α-helicity as a function of increasing Ca2+ concentration
(Figure 3.12C). On the other hand, the double modified mutant shows a resistance to
refolding and remains in a persistent reduced α-helical state as a function increasing Ca2+
levels (Figure 3.12D). Together, these binding affinity data reveal a remarkable sensitivity of
EFSAM to any modification associated with the Asn131 or Asn171 sites despite the
peripheral localization of these residues far from the EF-hand Ca2+ coordinating residues;
further, double mutation and/or modification of the Asn131 and Asn171 sites further
potentiates weaker binding and leaves the EFSAM core in a persistently partially unfolded
state.
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Figure 3.12. Ca2+ binding curves derived from changes in far-UV CD ellipticity as a
function of Ca2+ concentration. (A) Unmodified wild-type and mutant EFSAM Ca2+
binding curves acquired in 20 mM Tris, 150 mM NaCl, 1 mM TCEP, pH 7.5. (B) Wildtype and gl-modified mutant EFSAM Ca2+ binding curves acquired in 20 mM Tris, 150
mM NaCl, pH 7.5. The binding experiments were performed at 4 °C with increasing
CaCl2 concentrations from 0 mM to 16.2 mM. All binding curves are constructed from
n=3 separate experiments as mean responses ± SEM. (C) Representative far-UV CD
spectral changes with increasing Ca2+ concentrations of wild-type EFSAM (from n=3
titrations). (D) Representative far-UV CD spectral changes with increasing Ca2+
concentrations of gl-Asn131Cys/gl-Asn171Cys EFSAM (from n=3 titrations).
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Table 3.2. Summary of the equilibrium dissociation constants (Kd) extracted from the
far-UV CD-derived Ca2+ binding curves.
Kd (mM) a
Wild-type

0.18 ± 0.01

Asn131Cys

1.41 ± 0.48

Asn171Cys

1.95 ± 0.58

Asn131Cys/Asn171Cys

4.38 ± 2.33

gl-Asn131Cys

0.66 ± 0.11

gl-Asn171Cys

1.04 ± 0.18

gl-Asn131Cys/gl-Asn171Cys

9.94 ± 6.66

aK

was extracted using a one site-binding model that takes into account protein
concentration.
d
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3.5 Neo-glycosylation alters Ca2+-dependent oligomerization
propensity of EFSAM.
The Ca2+ sensitivity of EFSAM protein oligomerization was assessed using static
light scattering (SLS) measurements. All samples were centrifuged for 15,000 g and 5 min (4
°C) to remove high scattering protein aggregates prior to the measurements. For each wildtype, mutant and modified-mutant sample a baseline SLS intensity in the presence of 5 mM
Ca2+ was determined. Ca2+-sensitive oligomerization was monitored as the increase in SLS
intensity upon the addition of 10-fold excess EDTA. The time averaged SLS intensity is
shown prior to and after the addition of the EDTA (Figure 3.13A). As expected, the wildtype EFSAM protein showed a dramatic increase in SLS intensity upon Ca2+ chelation
indicative of Ca2+-depletion-induced oligomerization. The single mutant EFSAMs
maintained the ability to undergo Ca2+-depletion-dependent oligomerization; however, the
doubly mutated Asn131Cys/Asn171Cys EFSAM did not respond to Ca2+-chelation.
Similarly, the gl-Asn131Cys and the gl-Asn131Cys/gl-Asn171Cys protein solutions did not
show increased SLS intensity upon EDTA addition indicative of a Ca2+-insensitivity.
Conversely, the gl-Asn171Cys protein showed an increased SLS after Ca2+ chelation as
observed for wild-type EFSAM.
The

Ca2+

insensitivity

of

Asn131Cys/Asn171Cys,

gl-Asn131Cys

and

gl-

Asn131Cys/gl-Asn131Cys may reflect the instability of these proteins which were the least
thermally stable in the presence of Ca2+ (Table 3.1). The Asn131Cys, Asn171Cys and the glAsn171Cys all had a similar Tm and all were responsive to Ca2+ chelation (Table 3.1). Thus, I
hypothesized that I did not observe persistently high SLS intensity for the
Asn131Cys/Asn171Cys, gl-Asn131Cys and gl-Asn131Cys/gl-Asn131Cys proteins due to the
centrifugation steps which removes protein aggregates. Therefore, to confirm that the
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Asn131Cys/Asn171Cys, gl-Asn131Cys and gl-Asn131Cys/gl-Asn131Cys proteins were preaggregated, I re-suspended the pellets formed after centrifugation and measured the SLS
intensity as an indicator of aggregation state. The samples with low SLS intensity before and
after EDTA addition all exhibited significantly higher SLS intensity compared to wild-type
EFSAM prior to EDTA addition, suggesting that significantly more protein aggregates
formed even in the presence of Ca2+ compared to control (Figure 3.13B). Taken together,
these light scattering data suggest that modifications of EFSAM at the Asn131 and Asn171
sites increase the propensity for EFSAM oligomerization.
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Figure 3.13. Oligomerization propensity of EFSAM proteins assessed by SLS intensity.
(A) Ca2+-depletion dependent oligomerization assessed after chelation of Ca2+. SLS intensity
is shown before and after Ca2+ chelation using EDTA for each protein sample. Statistical
analysis is a two-way ANOVA with Bonferroni multiple comparisons test comparing SLS
intensity before and after 50 mM EDTA addition within each group; *p<0.0001. (B) Ca2+depletion independent oligomerization assessed in the absence of Ca2+ chelation. SLS
intensity of the resuspended aggregates pelleted by centrifugation is shown for each protein
sample. Statistical analysis was performed using one-way ANOVA with Dunnett multiple
comparisons test to the wild-type control group; *p<0.05, **p<0.0001. All data in (A) and
(B) are of n=3 separate experiments acquired in 5 mM CaCl2 20 mM Tris, 150 mM NaCl, 1
mM TCEP for unmodified mutants or no TCEP for modified mutants, pH 7.5.
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3.6 Blocking EFSAM glycosylation within full-length STIM1
suppresses SOCE.
The ability of the wild-type and mutant STIMs to regulate Ca2+ uptake was tested
using fura2 ratiometric fluorescence experiments using live HEK293 cells stably expressing
YFP-Orai1. HEK293-Orai1 cells were transiently transfected with wild-type monomeric
cherry tagged STIM1 (mChSTIM1) or the corresponding single Asn131Gln or Asn171Gln or
double Asn131Gln/Asn171Gln glycosylation-incompetent mutants. Passive depletion of the
ER Ca2+ store using TG caused a transient release of Ca2+ from the lumen that was not
significantly different between the five groups (i.e., no transfection, mChSTIM1, mChSTIM1
Asn131Gln, mChSTIM1 Asn171Gln, mChSTIM1 Asn131Gln/Asn171Gln). However, upon
the addition of 0.5 mM CaCl2 to the external medium, the uptake of Ca2+ for cells transfected
with doubly mutated STIM1 (i.e., mChSTIM1 Asn131Gln/Asn171Gln) displayed a
significantly smaller rise in the fluorescence ratio, indicating there was lower Ca2+ uptake
from the extracellular space compared to that of wild-type mChSTIM1 and single mutant
expressing cells (Figure 3.14). Surprisingly, after supplementing the external medium with an
additional 3.5 mM CaCl2 both the mChSTIM1 and mChSTIM1 Asn131Gln/Asn171Gln
proteins induced similar levels of uptake, whereas the single mutants maintained the trend
observed at lower external CaCl2 of inducing higher levels of Ca2+ entry compared to the
double mutant. Taken together, these data show that blocking EFSAM glycosylation within
full-length STIM1 decreases SOCE-mediated Ca2+ influx at relatively low levels of external
Ca2+ consistent with a role for glycosylation in enhancing the oligomerization propensity of
the domain and activation of Orai1 channels, and intriguingly, relatively high levels of
external Ca2+ may differentially affect the function of glycosylated and nonglycosylated
STIM proteins.
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Figure 3.14. Assessment of SOCE mediated by wild-type and glycosylationincompetent full length STIM1 proteins in HEK293 live cells. (A) Changes in the
Fura-2 fluorescence ratio reporting the relative changes in the cytosolic Ca2+ levels
upon depletion of ER Ca2+ stores by external addition of 0.5 µM TG and 0.1 mM EGTA
(horizontal green bar). SOCE was monitored after the addition of 0.5 mM and 4.0 mM
excess CaCl2 to the external medium at the time points indicated by the yellow and
orange horizontal bars, respectively. (B) Maximal relative changes in the Fura-2
fluorescence ratio after 0.5 mM TG, 0.5 mM and 4.0 mM external CaCl2 additions.
Statistical analysis was performed with two-way ANOVA with Bonferroni multiple
comparisons test to the mChSTIM1 control group. *p<0.01, **p<0.001. Data in (A) and
(B) are from HEK293 cells stably expressing YFP-Orai1 and transiently co-expressing
wild-type (n=8), Asn131Gln (n=3), Asn171Gln (n=3) or Asn131Gln/Asn171Gln (n=14)
mChSTIM1.
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Chapter 4
Discussion
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4.1 Summary of key findings
Although the STIM1 glycosylation sites were identified over 15 years ago (Williams
et al., 2001, 2002), studies on how STIM1 N-glycosylation affects SOCE have been
inconsistent and ambiguous (Mignen et al., 2007; Csutora et al., 2008; Czyz et al., 2009;
Kilch et al., 2013). Therefore, this thesis investigated the effect of such glycosylation on the
biophysical properties and structure of the Ca2+ sensing EFSAM domain, as well as the
function of the modified domain within full-length STIM1. I hypothesized that neoglycosylation of the EFSAM domain alters the biophysical properties of the domain in a
manner that is intimately tied to the ability of STIM1 to regulate SOCE. In summary, the
double glucose-conjugated mutant EFSAM protein (i.e., gl-Asn131Cys/gl-Asn171Cys)
exhibited a partial loss in α-helical secondary structure even in the presence of Ca2+.
Consistent with this structural change, the double modified sample had the lowest thermal
stability compared to all other groups. Moreover, variation of the Asn131 or Asn171 sites
decreased the Ca2+ binding affinity, as well as revealed 3D structural perturbations localized
near the modification site(s) when examined by NMR. From oligomerization studies, doubly
mutated and doubly modified EFSAM samples showed increased oligomerization even in the
presence of Ca2+, implying an increased ability to initiate and activate SOCE. Consistent with
this notion, STIM1 functional studies showed a suppressed Ca2+ influx via the SOCE
pathway when glycosylation was blocked by mutation at the Asn131 and Asn171 sites. Thus,
my hypothesis was supported by my in vitro and mammalian cell culture results,
demonstrating that glycosylation of the EFSAM domain endows STIM1 with another layer
of regulation through modification of the Ca2+ sensing properties of the protein.
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4.2 Neo-glycosylation alters the fundamental Ca2+ sensing
properties EFSAM proteins.
4.2.1 Glycosylation structurally perturbs STIM1 EFSAM
STIM1 protein is activated when Ca2+ dissociates from its binding site, resulting in a
partial unfolding coupled with destabilization of the domain; moreover, it has been suggested
that the EF-hand domain of EFSAM adopts a “closed” conformation similar to CaM in the
absence of Ca2+ (Stathopulos et al., 2008), but the precise atomic resolution structure of the
apo state is unknown. Interestingly, I discovered that glucose-conjugated EFSAM proteins
(i.e. gl-Asn131Cys/gl-Asn171Cys) displayed a significantly lower percentage α-helicity
compared to wild-type EFSAM proteins, suggesting a constitutive partial loss in α-helicity in
the presence of Ca2+ (Figure 3.1). This result is supported by my thermal stability studies
(Figure 3.2) which showed that gl-Asn131Cys/gl-Asn171Cys had the lowest thermal stability
(Tm ~37.8 °C), a value almost 11°C lower than that of the wild-type Tm (Table 3.1). These
findings imply that even in the presence of Ca2+, fully glycosylated EFSAM within STIM1
would be partially unfolded and STIM1 would be activated. However, it is important to note
that the non-conserved luminal region of STIM1 (i.e. residues 23-57) stabilizes the EFSAM
core domain by ~15 °C (Stathopulos et al., 2009). Thus, the double glycosylation of EFSAM
counteracts the stabilization caused by the non-conserved N-terminal residues by
destabilizing the conserved EFSAM domain, thereby adapting the protein for a role in ER
Ca2+ sensing associated with SOCE activation.
It has been previously shown that a balance between EF-hand Ca2+ binding affinity
and SAM domain stability tunes the two human homologues of STIM1 and STIM2 to
specific roles as a basal Ca2+ homeostasis regulator (i.e., STIM2) and a robust SOCE
ON/OFF regulator (i.e., STIM1) (Zheng et al., 2011). STIM1 has a higher Ca2+ binding
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affinity and a lower SAM domain stability, and so it remains inactive after small reductions
of ER luminal Ca2+. STIM2 has a lower Ca2+ binding affinity, but a higher SAM domain
stability, and so it is active even after small levels of ER luminal Ca2+ depletion. However,
the lower SAM domain stability of STIM1 makes it robustly oligomerize after a larger
magnitude ER Ca2+ depletion, while the higher SAM domain stability of STIM2 makes it less
oligomerization prone after ER Ca2+ depletion (Zheng et al., 2011). While the addition of the
non-conserved luminal residues increases both Ca2+ binding affinity (Stathopulos laboratory,
unpublished data) and stability (Stathopulos et al., 2009), my data suggest that the double
glycosylation, which is specific only to STIM1, contributes to this balance of Ca2+ binding
affinity and stability by shifting STIM1 EFSAM to even lower binding affinity and stability,
thus making STIM1 a robust ON/OFF regulator of SOCE.
From the differences observed in the secondary structural characteristics after glucose
conjugation to the EFSAM domain, I expected the modification would also alter the 3D
protein structure of this domain. Indeed, solution NMR spectroscopy demonstrated CSPs in
the 1H-15N HSQC spectra of EFSAM as a result of the modification(s). For the singly
modified EFSAM samples (i.e. gl-Asn131Cys or gl-Asn171Cys), CSPs, and thus structural
changes, were localized close to the modification sites in 3D space (i.e., ~10 Å maximum
distance; Figures 3.5, 3.8). Interestingly, for the double-modified gl-Asn131Cys/glAsn171Cys protein, the CSPs appeared to be largely an additive function of the individual
modifications (Figure 3.10). This result was somewhat unexpected because my far-UV CD
analyses showed a significantly reduced α-helicity for the doubly modified protein (Figure
3.1), suggesting a potential synergistic perturbation. However, it is important to note that the
double modified EFSAM protein tended to oligomerize (see below) even in the Ca2+ loaded
state, and the fraction of oligomerized protein would not be observable in the standard HSQC
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experiments due to size limitations of the standard NMR experiments. It is conceivable that
the doubly modified protein exists in multiple conformations, with the oligomerized partially
unfolded state not visible in the NMR spectrum. In addition to the CSPs, the doubly modified
spectrum exhibited a considerable loss in peak intensity that could be caused by multiple
conformations and/or increased homotypic protein-protein interactions.

4.2.2 Glycosylation lowers the Ca2+ affinity of STIM1 EFSAM
Because STIM1 protein activation is initiated by dissociation of Ca2+ from its binding
site, I also examined the effect of neo-glycosylation on EFSAM Ca2+ binding affinity. All
mutated or modified EFSAM proteins exhibited a decreased Ca2+ binding affinity compared
to the wild-type unmodified EFSAM (Table 3.2). However, the apparent Kd was highest (i.e.
weakest affinity) for the samples that were doubly mutated or doubly modified. Considering
Ca2+ levels in the ER lumen vary from ~100 to 800 µM, the Kd values estimated for the
double mutated or double modified EFSAM proteins appear too high to respond to the range
of changes in ER luminal Ca2+ levels. However, as mentioned above, the STIM1 nonconserved N-terminal region greatly stabilizes the core EFSAM domain (Stathopulos et al.,
2009), and thus, I believe that the weakened Ca2+ binding affinity caused by glycosylation
may compensate for the stabilization and increased affinity endowed by the variable Nterminal region.

4.2.3 Glycosylation enhances oligomerization of STIM1 EFSAM
Activated STIM1 forms oligomers which then translocate to ER-PM junctions where
puncta form (Liou et al., 2005, 2007; Zhang et al., 2005). This process initiates Ca2+ influx
through the SOCE pathway after coupling and activating Orai1 channels. It has been shown
that artificial oligomerization of the luminal domain of STIM1 is sufficient to induce
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translocation and activation of Orai1 channels (Luik et al., 2008). Therefore, oligomerization
of EFSAM is a fundamental initiation mechanism for STIM1 and SOCE activation. My data
showed that neo-glycosylation results in EFSAM partial unfolding, decreased stability and
lower Ca2+ binding affinity that could play a role in increased protein activation. Thus,
EFSAM oligomerization was studied in response to glucose modification. As predicted, glAsn131Cys/gl-Asn171Cys protein demonstrated persistent oligomerization even in the
presence of Ca2+ (Figure 3.13). Interestingly, the double mutant EFSAM (i.e.
Asn131Cy/Asn171Cys) as well as gl-Asn131Cys EFSAM also exhibited oligomers in the
presence of Ca2+. At the same time, the thermal stability data indicated that
Asn131Cys/Asn171Cys, gl-Asn131Cys, and gl-Asn131Cys/gl-Asn171Cys proteins had the
lowest Tm values of 41.5 °C, 42.0 °C, and 37.8 °C respectively, reinforcing the intimate link
between oligomerization propensity and stability.

4.3 SOCE is suppressed after blocking of STIM1 glycosylation
in mammalian cells.
While my biophysical studies indicated double glucose modification lowers Ca2+
binding affinity, destabilizes, partially unfolds and increases protein oligomerization of
EFSAM, the link between glycosylation of EFSAM and full-length STIM1 function in the
cell was unclear based on contradictory findings from multiple groups (see Chapter 1.6.1).
Therefore, I conducted fura2 cytosolic Ca2+ imaging to examine the effect of glycosylation
on STIM1 function and SOCE. Remarkably, I discovered that at relatively low levels of
extracellular CaCl2 (i.e. ~0.5 mM) cells expressing the mChSTIM1 Asn131Gln/Asn171Gln
double mutant which blocks glycosylation at those mutated sites displayed significantly less
Ca2+ influx compared to wild-type (Figure 3.14). This data at relatively low extracellular
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CaCl2 is fully consistent with my biophysical studies where glucose-modification enhances
EFSAM oligomerization via decreased Ca2+ binding affinity, partial unfolding and
destabilization. Thus, in the full-length STIM1 context, glycosylation of the EFSAM region
enhances the activation of the molecule in response to ER Ca2+ depletion. These differences
observed at ~0.5 mM external CaCl2 levels are consistent with a previous study using a
similar concentration of external CaCl2 with cells expressing Asn to Gln double mutant
STIM1 (Kilch et al., 2013).
Interestingly, after the initial uptake at ~0.5 mM CaCl2, supplementing the external
medium with an additional 3.5 mM CaCl2 (i.e., ~4.0 mM total external bath CaCl2) decreased
Ca2+ influx for the wild-type mChSTIM1 compared to the single Asn131Gln or Asn171Gln
mutant mChSTIM1. It has been known that SOCE can be regulated by extracellular Ca2+ for
over 20 years (Petersen & Berridge, 1994), and it is well established that a fraction of STIM1
is located on the PM with the N-terminus facing the extracellular medium (Manji et al.,
2000; Zhang et al., 2005; Lopez et al., 2006; Spassova et al., 2006). More recently, a study
using human platelets demonstrated an extracellular Ca2+ dependent decrease in the rate of
Mn2+ uptake through Orai1 channels at extracellular Ca2+ levels between 0 – 3 mM (Jardín et
al., 2009). Further, this inhibition was attributed to PM localized STIM1 since external
incubation of the cells with an antibody that recognizes STIM1 eliminated the inhibitory
effect without cell permeabilization (Jardín et al., 2009). Thus, I speculate that the
differences in SOCE observed at 0.5 mM and 4.0 mM extracellular Ca2+ could be driven by
the inhibitory effects of extracellular Ca2+. The blocked glycosylation of mChSTIM1
Asn131Gln or mChSTIM1 Asn171Gln would prevent targeting to the PM (Williams et al.,
2002) and any inhibitory effects exerted by extracellular Ca2+ on these proteins. Thus, SOCE
mediated by the wild-type mCh-STIM1 would be inhibited by the high extracellular Ca2+,
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while the ER-resident single and double glycosylation mutants would be unaffected, resulting
in the significantly lower uptake of the wild-type compared to the single mutants. This
intriguing inhibitory effect of extracellular Ca2+ may also help explain some of the
ambiguities observed in the past glycosylation studies with single as well as double mutant
STIM1s (Mignen et al., 2007; Csutora et al., 2008; Czyz et al., 2009; Kilch et al., 2013).
However, we cannot rule out the possibility that suppressed SOCE was due to the mutation
rather than blocked N-glycosylation. Thus, further investigation on the biophysical effects of
the Gln mutation with respect to STIM1 function is needed for a more complete study.
Nevertheless, my experiments using HEK293 cells showed that fully preventing STIM1
luminal domain glycosylation suppresses the SOCE activity at relatively low external Ca2+
levels, consistent with my in vitro biophysical and structural assessments.

4.4 Future studies
My work demonstrated that glycosylation of the EFSAM domain results in increased
protein activation and function by altering the structure such that the protein partially loses αhelicity in the presence of Ca2+, causes destabilization and lowers Ca2+ binding affinity.
Further, I found that blocking glycosylation in the full-length STIM1 molecules suppresses
SOCE activation at relatively low external Ca2+ levels. While the NMR data identified
regions of EFSAM that are structurally perturbed upon glucose attachment, solving the 3D
structure of EFSAM in the modified state(s) would reveal precisely how the tertiary structure
and fold of EFSAM changes in response to the modifications. This proposed structural work
could provide new high-resolution insights into the oligomerization-prone EFSAM
conformation, data that are currently lacking in the field. Additionally, it is important to
assess the effects of mature glycans on the EFSAM biophysical properties and structure in
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the singly or doubly attached scenarios. Experiments with mature glycans may reveal
additional reasons behind the Ca2+-dependent effect on SOCE I observed in the cell culture
experiments.
Previous studies have found that the Asn131 and Asn171 residues on STIM1 proteins
are glycosylated endogenously (Williams et al., 2001, 2002). However, the exact fraction of
STIM1 proteins that is modified in this regard is unclear; moreover, the glycosylation levels
in different tissues and cell types are unknown. Therefore, determining how partial protein
modification affects the overall function of SOCE is another intriguing study to be performed
to further understand the role of this cellular protein modification on SOCE. An experiment
where incompletely modified EFSAM proteins are mixed with different percentages of
modified EFSAMs to mimic the various scenarios in the cells would assess if modified
EFSAM proteins can trigger unmodified EFSAM activation, and thus, an increase in SOCE
function.
Lastly, the SOCE pathway is heavily involved and studied in conjunction with many
physiological diseases such as SCID, heart diseases and cancer (Roos et al., 2005; Yang et
al., 2009; Vashisht et al., 2015; Pla et al., 2016). Since this thesis shows a role of
glycosylation in protein activation and function, additional research on how glycosylation
levels change in various diseases could provide important clues into the changes in SOCE
that are involved in the manifestation of disease. For example, in certain cancers such as the
breast cancer, it is already known that Ca2+ uptake through SOCE is increased; furthermore,
there is increased protein glycosylation indicated by increased glycan levels in metastasizing
breast cancer cells (Yang et al., 2009; Kölbl et al., 2015; Vashisht et al., 2015). Therefore,
comparing the amount of endogenously glycosylated STIM1 proteins in normal and cancer
cells would provide a mechanistic basis for the increased SOCE apart from changes in
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protein expression patterns. Importantly, my work on the mechanisms of glycosylationinduced enhanced STIM1 activation may lead to a new rationale for the development of
therapeutics by modulating STIM1 function and SOCE.

4.5 Overall Conclusion
Protein modifications, such as glycosylation, are important not only for proper
trafficking of molecules within the cell, but also for fine-tuning protein functions. Therefore,
studying how these modifications alter the biophysical properties of proteins is crucial for
understanding the mechanisms of function. The ER Ca2+ sensor for the SOCE pathway
STIM1 is glycosylated at residues Asn131 and Asn171. This thesis investigated the effect of
glucose conjugation on the biophysical properties of the Ca2+ sensing STIM1 EFSAM
domain that mediates protein activation. Through my analysis of α-helicity, thermal stability,
3D structure, Ca2+ binding affinity, and oligomerization, I found that glycosylation of the two
Asn residues at the 131 and 171 residue sites of the EFSAM domain increases protein
activation through changes in structure, Ca2+ binding affinity, oligomerization and ability to
signal Ca2+ influx in cells (Table 4.1). Remarkably, the Asn131Cys and Asn171Cys
mutations without any glucose conjugation promoted changes to critical Ca2+ sensing
properties of EFSAM that were further enhanced after glucose attachment. This discovery
indicates that even though Asn131 and Asn171 sites are at the structural periphery of
EFSAM, these locations play important roles in the folding, structure and Ca2+ sensing
mechanism of EFSAM.
There are several novel aspects to this thesis research. First, I established a sitespecific chemical approach to conjugating sugars to EFSAM and studying the structural and
biophysical consequences of this attachment. I show that neo-glycosylation of the Asn131
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and Asn171 sites within the vital EFSAM Ca2+ sensing domain results in structural
perturbations that lead to modified folding, stability, Ca2+ binding affinity and
oligomerization, properties that ultimately favor STIM1 activation. My work provides the
first structural and mechanistic insights into how N-glycosylation effects the Ca2+ sensing
properties of STIM1 with respect to the regulation of SOCE, and importantly, a framework
for future studies investigating how different glycans at various stages of processing effect
STIM1 Ca2+ sensing and SOCE activity. Collectively, my data suggests that glycosylation of
STIM1 makes this protein more responsive to ER Ca2+ store depletion by decreasing
foldedness, stability and Ca2+ binding affinity. Such a mechanism counteracts the
stabilization caused by the non-conserved far N-terminal residues, making STIM1 very well
suited as an ON/OFF activator of SOCE. Thus, modified STIM1 would be more sensitive to
fluctuating Ca2+ levels in the ER, resulting in more fine responses to maintain ER Ca2+ levels
at a certain concentration, while meeting the cytosolic Ca2+ demand (Figure 4.1).

83

Table 4.1. Summary of the changes in EFSAM Ca2+ sensing function and SOCE activation
due to N-glycosylation.
✗ Glycosylation

✓ Glycosylation
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é

ê
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é

ê
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Figure 4.1. Proposed model of non-glycosylated and N-glycosylated STIM1-mediated SOCE activation. Decreases in ER stored Ca2+ levels
results in EFSAM destabilization coupled dimerization/oligomerization of the luminal domain which induces a cytosolic CC1-CC2-CC3 extension
and conformational rearrangement. The present thesis work suggests that N-glycosylation promotes EFSAM domain activation via enhanced
destabilization resulting in increased activation of Orai1 channels compared to non-glycosylated STIM1 proteins, depicted here as a greater number
of active channels at ER-PM junctions.

K
C

Orai1

N-Glycosylated ER STIM1

CC3
CC3
CC3
CC3

NNNN

KK

closed

vs.

CC1
CC1
CC1
CC1

[Ca2+] = 100 µM

puncta

K K Orai1

Non-glycosylated ER STIM1

CC2
CC2
CC2
CC2

ER

PM

Extracellular space
[Ca2+] = 1000 µM open

CC3
CC3
CC3
CC3

84

85

References

86

Avezov E, Frenkel Z, Ehrlich M, Herscovics A & Lederkremer GZ (2008). Endoplasmic
reticulum ( ER ) mannosidase I is compartmentalized and required for N-Glycan
trimming to Man5–6GlcNAc2 in glycoprotein ER-associated degradation. Mol Biol Cell
19, 216–225.
Baba Y, Hayashi K, Fujii Y, Mizushima A, Watarai H, Wakamori M, Numaga T, Mori Y,
Iino M, Hikida M & Kurosaki T (2006). Coupling of STIM1 to store-operated Ca2+
entry through its constitutive and inducible movement in the endoplasmic reticulum.
PNAS 103, 16704–16709.
Berridge MJ (1993). Inositol trisphosphate and calcium signalling. Nature 361, 315–325.
Berridge MJ (2002). The endoplasmic reticulum: a multifunctional signaling organelle. Cell
Calcium 32, 235–249.
Berridge MJ, Bootman MD & Roderick HL (2003). Calcium signalling: dynamics,
homeostasis and remodelling. Nat Rev Mol Cell Biol 4, 517–529.
Bogeski I, Al-Ansary D, Qu B, Niemeyer BA, Hoth M, Bogeski I, Al-ansary D, Qu B,
Niemeyer BA, Hoth M, Al-ansary D, Qu B & Barbara A (2010). Pharmacology of
ORAI channels as a tool to understand their physiological functions. Expert Rev Clin
Pharmacol 3, 291–303.
Bootman MD, Collins TJ, Peppiatt CM, Prothero LS, MacKenzie L, De Smet P, Travers M,
Tovey SC, Seo JT, Berridge MJ, Ciccolini F & Lipp P (2001). Calcium signalling—an
overview. Semin Cell Dev Biol 12, 3–10.
Boscher C, Dennis JW & Nabi IR (2011). Glycosylation, galectins and cellular signaling.
Curr Opin Cell Biol 23, 383–392.
Cai X (2007a). Molecular evolution and functional divergence of the Ca2+ sensor protein in
store-operated Ca2+ entry: stromal interaction molecule. PLoS One 2, e609.
Cai X (2007b). Molecular evolution and structural analysis of the Ca2+ release-activated Ca2+
channel subunit, Orai. J Mol Biol 368, 1284–1291.
Chai Q, Wang X, Zeldin DC & Lee H (2013). Role of caveolae in shear stress-mediated
endothelium-dependent dilation in coronary arteries. Cardiovasc Res 100, 151–159.
Chin D & Means AR (2000). Calmodulin: a prototypical calcium sensor. Trends Cell Biol
10, 322–328.
Clapham DE (1995). Calcium signaling. Cell 80, 259–268.
Csutora P, Peter K, Kilic H, Park KM, Zarayskiy V, Gwozdz T & Bolotina VM (2008).
Novel role for STIM1 as a trigger for calcium influx factor production. J Biol Chem
283, 14524–14531.

87

Czyz A, Brutkowski W, Fronk J, Duszyński J & Zabłocki K (2009). Tunicamycin
desensitizes store-operated Ca2+ entry to ATP and mitochondrial potential. Biochem
Biophys Res Commun 381, 176–180.
Darbellay B, Arnaudeau S, Bader CR, Konig S & Bernheim L (2011). STIM1L is a new
actin-binding splice variant involved in fast repetitive Ca2+ release. J Cell Biol 194,
335–346.
Dehaven WI, Smyth JT, Boyles RR, Putney JW & Carolina N (2007). Calcium inhibition and
calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium
channels. J Biol Chem 282, 17548–17556.
Dennis JW, Lau KS & Nabi IR (2009). Adaptive regulation at the cell surface by Nglycosylation. Traffic 10, 1569–1578.
Estrada IA, Donthamsetty R, Debski P, Zhou M-H, Zhang SL, Yuan JX-J, Han W & Makino
A (2012). STIM1 restores coronary endothelial function in Type 1 diabetic mice. Circ
Res 111, 1166–1175.
Farrow NA, Muhandham JR, Singer AU, Pascal SM, Kay CM, Gish G, Shoelson SE,
Pawson T, Forman-kay JD & Kay LE (1994). Backbone dynamics of a free and a
phosphopeptide-complexed src homology 2 domain studied by 15N NMR relaxation.
Biochemistry 33, 5984–6003.
Feske S (2007). Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol
7, 690–702.
Frischauf I, Muik M, Derler I, Bergsmann J, Fahrner M, Schindl R, Groschner K & Romanin
C (2009). Molecular determinants of the coupling between STIM1 and Orai Channels. J
Biol Chem 284, 21696–21706.
Fuchs A, Kutterer S, Tobias M, Duda J, Sch B, Liss B, Keller BU & Roeper J (2013).
Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons
of the SOD1 G93A mouse model of amyotrophic lateral sclerosis. J Physiol 591, 2723–
2745.
Gerlach JQ, Sharma S & Leister KJ (2012). A tight-knit group: protein glycosylation,
endoplasmic reticulum stress and the unfolded protein reponseed. Springer, Dordrecht.
Glitsch MD, Bakowski D & Parekh AB (2002). Store-operated Ca2+ entry depends on
mitochondrial Ca2+ uptake. EMBO J 21, 6744–6754.
Graham SJL, Dziadek MA & Johnstone LS (2011). A cytosolic STIM2 preprotein created by
signal peptide inefficiency activates ORAI1 in a store-independent manner. J Biol Chem
286, 16174–16185.

88

Gudlur A, Quintana A, Zhou Y, Hirve N, Mahapatra S & Hogan PG (2014). STIM1 triggers
a gating rearrangement at the extracellular mouth of the Orai1 channel. Nat Commun 5,
1–11.
Gwack Y, Srikanth S, Feske S, Cruz-guilloty F, Oh-hora M, Neems DS, Hogan PG & Rao A
(2007). Biochemical and functional characterization of Orai proteins. J Biol Chem 282,
16232–16243.
Hill SJ (1990). Distribution, properties, and functional characteristics of three classes of
histamine receptor. Am Soc Pharmacol Exp Ther 42, 46–73.
Hogan PG, Hogan PG, Chen L & Chen L (2003). Transcriptional regulation by calcium,
calcineurin. Genes Dev 17, 2205–2232.
Horinouchi T, Higashi T, Higa T, Terada K, Mai Y, Aoyagi H, Hatate C, Horiguchi M,
Harada T & Miwa S (2012). Different binding property of STIM1 and its novel splice
variant STIM1L to Orai1, TRPC3, and TRPC6 channels. Biochem Biophys Res
Commun 428, 252–258.
Hou X, Pedi L, Diver MM & Long SB (2012). Crystal structure of the calcium releaseactivated calcium channel Orai. Science (80- ) 338, 1308–1313.
Huang Y, Zhou Y, Wong H, Chen Y, Chen Y, Wang S, Liu A & Yang JJ (2009). A single
ER-hand isolated from STIM1 forms dimer in the absence and presence of Ca2+. FEBS J
276, 5589–5597.
Ikura M, Minowa O & Hikichi K (1985). Hydrogen bonding in the carboxyl-terminal halffragment 78-148 of calmodulin as studied by two-dimensional nuclear magnetic
resonance. Biochemistry 24, 4264–4269.
Jackson TR, Patterson SI, Thastrup O & Hanley MR (1988). A novel tumour promoter,
thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol
phosphates in NG115-401L neuronal cells. Biochem J 253, 81–86.
Jaiswal MK, Zech W, Goos M, Leutbecher C, Ferri A, Zippelius A, Carrì MT, Nau R &
Keller BU (2009). Impairment of mitochondrial calcium handling in a mtSOD1 cell
culture model of motoneuron disease. BMC Neurosci; DOI: 10.1186/1471-2202-10-64.
Janis R & Triggle D (1983). New developments in Ca2+ channel antagonists. J Med Chem 26,
775–785.
Jardín I, López JJ, Redondo PC, Salido GM & Rosado JA (2009). Store-operated Ca2+ entry
is sensitive to the extracellular Ca2+ concentration through plasma membrane STIM1.
BBA - Mol Cell Res 1793, 1614–1622.

89

Kay LE, Keifer P & Saarinen T (1992). Pure absorption gradient enhanced heteronuclear
single quantum correlation spectroscopy with improved sensitivity. J Am Chem Soc 114,
10663–10665.
Kilch T, Alansary D, Peglow M, Dorr K, Rychkov G, Rieger H, Peinelt C & Niemeyer BA.
(2013). Mutations of the Ca2+-sensing stromal interaction molecule stim1 regulate Ca2+
influx by altered oligomerization of stim1 and by destabilization of the Ca2+ channel
orai1. J Biol Chem 288, 1653–1664.
Kölbl AC, Andergassen U & Jeschke U (2015). The role of glycosylation in breast cancer
metastasis and cancer control. Front Oncol 5, 1–5.
Kretsinger RH & Nockolds CE (1973). Carp muscle calcium-binding protein. J Biol Chem
248, 3313–3326.
van Leeuwen JE & Samelson LE (1999). T cell antigen-receptor signal transduction. Curr
Opin Immunol 11, 242–248.
Leurs R, Smit MJ & Timmerman H (1995). Molecular aspects of histamine receptors.
Pharmacol Ther 66, 413–463.
Liou J, Fivaz M, Inoue T & Meyer T (2007). Live-cell imaging reveals sequential
oligomerization and local plasma membrane targeting of stromal interaction molecule 1
after Ca2+ store depletion. Cell Biol 104, 9301–9306.
Liou J, Kim ML, Heo W Do, Jones JT, Myers JW, Ferrell JE & Meyer T (2005). STIM is a
Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 15, 1235–
1241.
Lis A, Peinelt C, Beck A, Parvez S, Monteilh-zoller M, Fleig A & Penner R (2007).
CRACM1, CRACM2, and CRACM3 are store-operated Ca2+ channels with distinct
functional properties. Curr Biol 17, 794–800.
Lopez JJ, Salido M, Pariente A & Rosado JA (2006). Interaction of STIM1 with
Endogenously Expressed Human Canonical TRP1 upon Depletion of Intracellular Ca2+
Stores. J Biol Chem 281, 28254–28264.
Lucas JA, Miller AT, Berg LJ & Berg LJ (2003). The role of Tec family kinases in T cell
development and function. Immunol Rev 191, 119–138.
Luik RM, Wang B, Prakriya M, Wu MM, Lewis RS & Physiology C (2008).
Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation.
Nature 454, 538–542.
Lytton J, Weslin M & Hanley MR (1991). Thapsigargin inhibits the sarcoplasmic or
endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 26, 17067–
17071.

90

Manji SS, Parker NJ, Williams RT, van Stekelenburg L, Pearson RB, Dziadek M & Smith PJ
(2000). STIM1: a novel phosphoprotein located at the cell surface. Biochim Biophys
Acta 1481, 147–155.
Mercer JC, Dehaven WI, Smyth JT, Wedel B, Boyles RR, Bird GS, Putney JW & Carolina N
(2006). Large store-operated calcium selective currents due to co-expression of Orai1 or
Orai2 with the intracellular calcium sensor, Stim1. J Biol Chem 281, 24979–24990.
Miao Y, Miner C, Zhang L, Hanson PI, Dani A & Vig M (2013). An essential and NSF
independent role for α-SNAP in store-operated calcium entry. Elife 2, e00802.
Mignen O, Thompson JL & Shuttleworth TJ (2007). STIM1 regulates Ca2+ entry via
arachidonate-regulated Ca2+-selective (ARC) channels without store depletion or
translocation to the plasma membrane. J Physiol 579, 703–715.
Mignen O, Thompson JL & Shuttleworth TJ (2008). Orai1 subunit stoichiometry of the
mammalian CRAC channel pore. J Physiol 586, 419–425.
Muller MS, Pedersen SE, Walls AB, Waagepetersen HS & Bak LK (2015). Isoform-selective
regulation of glycogen phosphorylase by energy deprivation and phosphorylation in
astrocytes. Glia 63, 154–162.
Nilsson T, Au CE & Bergeron JJM (2009). Sorting out glycosylation enzymes in the golgi
apparatus. FEBS Lett 583, 3764–3769.
Parod RJ & Putney JW (1978). The role of calcium in the receptor mediated control of
potassium permeability in the rat lacrimal gland. J Physiol 281, 371–381.
Pearse BR & Hebert DN (2010). Lectin chaperones help direct the maturation of
glycoproteins in the endoplasmic reticulum. Biochim Biophys Acta 1803, 684–693.
Petersen CCH & Berridge MJ (1994). The regulation of capacitative calcium entry by
calcium and protein kinase C in Xenopus oocytes. J Biol Chem 269, 32246–32253.
Pla AF, Kondratska K & Prevarskaya N (2016). STIMs and ORAIs proteins: crucial roles in
hallmarks of cancer. Am J Physiol - Cell Physiol 10, c509–c519.
Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A & Hogan PG (2006). Orai1 is an essential
pore subunit of the CRAC channel. Nature 443, 230–233.
Putney JW (1976). Biphasic modulation of potassium release in rat parotid gland by
carbachol and phenylephrine. J Pharmacol Exp Ther 198, 375–384.
Putney JW (1986). A model for receptor-regulated calcium entry. Cell Calcium 7, 1–12.
Rasmussen H (1970). Cell communication, calcium ion, and cyclic adenosine
monophosphate. Am Assoc Adv Sci 170, 404–412.

91

Ringer S (1883). A further contribution regarding the influence of the different constituents
of the blood on the contraction of the heart. J Physiol 4, 29–42.3.
Roos J, DiGregorio PJ, Yeromin A V, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak
JA, Wagner SL, Cahalan MD, Velicelebi G & Stauderman KA (2005). STIM1, an
essential and conserved component of store-operated Ca2+ channel function. J Cell Biol
169, 435–445.
Schindl R, Frischauf I, Bergsmann J, Muik M, Derler I, Lackner B, Groschner K & Romanin
C (2009). Plasticity in Ca2+ selectivity of Orai1/Orai3 heteromeric channel. PNAS 106,
19623–19628.
Schlessinger J (2000). Cell signaling by receptor tyrosine kinases. Cell 103, 211–225.
Shaw P & Feske S (2013). Physiological and pathological functions of SOCE in the immune
system. Front Biosci (Elite Ed) 4, 2253–2268.
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, Thompson JD, Higgins
DG, Mcwilliam H, Remmert M & So J (2011). Fast, scalable generation of high-quality
protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7, 1–6.
Spassova MA, Soboloff J, He L, Xu W, Dziadek MA & Gill DL (2006). STIM1 has a plasma
membrane role in the activation of store-operated Ca2+ channels. PNAS 103, 4040–4045.
Stanley P (2011). Golgi glycosylation. Cold Srping Harb Perspect Biol 3, a005199.
Stanley P, Schachter H & Taniguchi N (2014). N-Glycans. Cold Spring Harbor, New York.
Stathopulos PB & Ikura M (2013a). Structure and function of endoplasmic reticulum STIM
calcium sensors. Elsevier Inc., Amsterdam.
Stathopulos PB & Ikura M (2013b). Structural aspects of calcium-release activated calcium
channel function. Channels 7, 1–10.
Stathopulos PB, Li G, Plevin MJ, Ames JB & Ikura M (2006). Stored Ca2+ depletion-induced
oligomerization of stromal interaction molecule 1 (STIM1) via the EF-SAM region. J
Biol Chem 281, 35855–35862.
Stathopulos PB, Schindl R, Fahrner M, Zheng L, Gasmi-Seabrook GM, Muik M, Romanin C
& Ikura M (2013). STIM1/Orai1 coiled-coil interplay in the regulation of store-operated
calcium entry. Nat Commun 4, 2963.
Stathopulos PB, Zheng L & Ikura M (2009). Stromal interaction molecule (STIM) 1 and
STIM2 calcium sensing regions exhibit distinct unfolding and oligomerization kinetics.
J Biol Chem 284, 728–732.

92

Stathopulos PB, Zheng L, Li G-Y, Plevin MJ & Ikura M (2008). Structural and mechanistic
insights into STIM1-mediated initiation of store-operated calcium entry. Cell 135, 110–
122.
Tamouza H, Chemouny JM, Kafkova LR, Berthelot L, Flamant M, Demion M, Mesnard L,
Paubelle E, Walker F, Tiwari MK, Camara NOS, Vrtovsnik F, Julian BA, Tissandie E,
Benhamou M, Novak J, Monteiro RC & Moura IC (2012). The IgA1 immune complex–
mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated
with glomerular damage in IgA nephropathy. Kidney Int 82, 1284–1296.
Thompson JL & Shuttleworth TJ (2013). How many Orai’s does it take to make a CRAC
channel? Sci Rep 3, 1961.
Treiman M, Caspersen C, Treiman M, Caspersen C & Brøgger S (1998). A tool coming of
age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases. Trends
Pharmacol Sci 19, 131–135.
Varga-Szabo D, Braun A & Nieswandt B (2011). STIM and Orai in platelet function. Cell
Calcium 50, 270–278.
Vashisht A, Trebak M & Motiani RK (2015). STIM and Orai proteins as novel targets for
cancer therapy. Am J Physiol - Cell Physiol 309, C457–C469.
Walsh CT, Garneau-Tsodikova S & Gatto Jr. GJ (2005). Protein posttranslational
modifications: the chemistry of proteome diversifications. Angew Chemie Int Ed 44,
7342–7372.
Whitmore L & Wallace BA (2004). DICHROWEB, an online server for protein secondary
structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res 32,
668–673.
Williams RT, Manji SS, Parker NJ, Hancock MS, Van Stekelenburg L, Eid JP, Senior P V,
Kazenwadel JS, Shandala T, Saint R, Smith PJ & Dziadek M a (2001). Identification
and characterization of the STIM (stromal interaction molecule) gene family: coding for
a novel class of transmembrane proteins. Biochem J 357, 673–685.
Williams RT, Senior P V., Van Stekelenburg L, Layton JE, Smith PJ & Dziadek M a. (2002).
Stromal interaction molecule 1 (STIM1), a transmembrane protein with growth
suppressor activity, contains an extracellular SAM domain modified by N-linked
glycosylation. Biochim Biophys Acta 1596, 131–137.
Yang S, Zhang JJ & Huang XY (2009). Orai1 and STIM1 are critical for breast tumor cell
migration and metastasis. Cancer Cell 15, 124–134.
Yeromin AV, Zhang SL, Jiang W, Yu Y, Safrina O & Cahalan MD (2006). Molecular
identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature
443, 226–229.

93

Zhang SL, Yeromin A V, Zhang XH, Yu Y, Safrina O, Penna A, Roos J, Stauderman KA &
Cahalan MD (2006a). Genome-wide RNAi screen of Ca2+ influx identifies genes that
regulate Ca2+ release-activated Ca2+ channel activity. PNAS 103, 9357–9362.
Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, Stauderman KA & Cahalan
MD (2005). STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from
the Ca2+ store to the plasma membrane. Nature 437, 902–905.
Zheng L, Stathopulos PB, Schindl R, Li G, Romanin C & Ikura M (2011). Auto-inhibitory
role of the EF-SAM domain of STIM proteins in store-operated calcium entry. PNAS
108, 1337–1342.

94

Curriculum Vitae
Name:

Yoo Jung Choi

Post-secondary
Education and
Degrees:

Western University
London, Ontario, Canada
Honors Specialization BMSc
2010-2014
Western University
London, Ontario, Canada
MSc in Physiology and Pharmacology
2014-2016

Honours and
Awards:

Dean’s Honor List
2011-2014
Western Graduate Research Scholarship
2014-2016
Ontario Graduate Scholarship
2014-2016
Physiology & Pharmacology Research Day
Graduate student poster presentation
2nd place in the Cell Biology category
2015

Related Work
Experience

Research Assistant
Western University
2012-2014
Teaching Assistant
Physiology 3120
Western University
2014-2016

Publications:
Stathopulos PB & Choi YJ (2016). Conformational changes mediating stromal
interaction molecule-1 function. Min Rev Med Chem. (In progress)
Choi YJ, Zhao Y, Bhattacharya M & Stathopulos PB (2016). Structural perturbations
induced by Asn131 and Asn171 glycosylation converge within the EFSAM core and
enhance stromal interaction molecule-1 mediated store operated calcium entry. BBA –
Mol Cell Res. (In review)

95

Presentations:
Physiology and Pharmacology Research Day
Title: The effect of neo-glycosylation on the structure and function of stromal
interaction molecule-1 luminal domain
Western University
London, ON
2015
London Health Research Day
Title: The effect of neo-glycosylation on the structure and function of stromal
interaction molecule-1 luminal domain
London, ON
2015
London Health Research Day
Title: The effect of neo-glycosylation on the structure and function of stromal
interaction molecule-1 luminal domain
London, ON
2016

